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Abstract
Background: Heart failure (HF) is a prevalent disease with a complex symptom
experience. Black women with Heart Failure preserved Ejection Fraction (HFpEF) are
especially burdened by symptoms, and their symptom experience is poorly understood.
Clustering HF symptoms to understand which symptoms are experienced together is a
potential option for helping patients recognize impending exacerbations.
Methods: The dissertation's first manuscript is an integrative review to examine the
current state of HF symptom cluster literature. The second manuscript explores the
feasibility and acceptability of a mixed methods HF symptom cluster study of Black
women with HFpEF (N=44) and presents preliminary symptom cluster results. The third
manuscript presents symptom experience themes from qualitative interviews (N=15) and
integrates those findings with quantitative questionnaire data.
Findings: An integrative review of HF symptom cluster literature revealed a need for
exploring the symptom experience of Black women with HFpEF using mixed methods. A
convergent-parallel mixed methods study protocol met feasibility benchmarks and was
deemed acceptable by Black women with HFpEF. Preliminary symptom clusters were
identified using quantitative symptom data from symptom questionnaires. Qualitative
themes emerged relating to the symptom experience and person, and mixed methods
integration provided additional key findings of concordance, discordance, and expansion.
Conclusion: This dissertation describes the symptom experience of Black women with
HFpEF, provides valuable information on the recruitment of an understudied population
and their acceptability of a study protocol, and builds the foundation for conducting a
mixed methods HF symptom cluster study with a larger sample in the future.
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Introduction
Background and Gaps in Knowledge
Heart failure (HF) is a severe cardiovascular disease in which up to 30% of
patients die within one year after diagnosis (1, 2). HF is the most common cause of
hospitalization in the U.S. for those over the age of 65, and almost 25% of patients with
HF will be readmitted within 6 months after discharge (3). Persons with HF experience a
complex and multifactorial array of symptoms that make symptom self-monitoring and
self-management difficult (1, 4-6).
HF symptoms are especially burdensome for Black patients and women. Black
Americans are 1.5 times more likely to develop HF compared to White Americans (7).
Black Americans also have a 2.5 times greater risk of dying from HF than White
Americans (7). Females with HF report more depression, worse quality of life and
symptom severity, and more frequent and longer hospitalization than males (2, 4, 8-10).
Females also are more likely to be diagnosed with Heart Failure preserved Ejection
Fraction (HFpEF) a type of HF caused by diastolic dysfunction in which relaxation of the
left ventricle is impaired from increased stiffness (2, 11, 12). This type of HF is poorly
understood, and more research is needed to characterize the symptom experience of
patients with HFpEF (2, 12).
Females with HF are diagnosed or referred to cardiologists later than males and
disproportionately receive fewer recommended therapies or less self-management
education (2, 13, 14). Black Americans with HF have been noted to have difficulty
recognizing and interpreting HF symptoms (7). An inadequate understanding of the
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symptom experience for Black females with HF may lead to delays in treatment and
ultimately result in avoidable hospitalizations from HF exacerbations (7).
So far, Black females have been underrepresented in heart failure symptom
cluster research. There is a critical need to examine the symptom experience of Black
women with HFpEF and how symptoms cluster in this population. This study aims to
examine how the intersection of such factors can impact symptom clusters and the
symptom experience of Black women with HFpEF using mixed methods.

Heart Failure Symptom Clusters
A symptom cluster is two or more symptoms that occur simultaneously in disease
(5). Knowledge about how symptoms cluster can help patients to recognize impending
exacerbations more easily, be used for developing more targeted and effective
interventions, and assist in determining risk for adverse health outcomes (5, 8, 15-30). A
small body of literature exists for HF symptom clusters that validates these potential uses
(5, 8, 15-30).
However, research that has been conducted in this area minimally examines sex
differences, does not include qualitative methodologies, and lacks racial and ethnic
diversity (5, 8, 15-30). Yet, sex/gender and race/ethnicity have a complex interaction that
influences health and should be considered when studying symptoms (31). Sex and
gender differences in symptom perception and impact are also prevalent in other chronic
diseases. Females with Chronic Obstructive Pulmonary Disorder (COPD) report higher
levels of anxiety and depression, worse quality of life, worse perceived control of
symptoms, and greater functional impairment (32-35). Women are noted to have
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increased pain sensitivity and risk, and women with Chronic Venous Disease (CVD)
were found to have worse neuropathic pain (burning, throbbing, and night cramps)
compared to males (36). Woman's sex/gender in asthma is associated with more severe
symptom intensity, frequency, and limitations from symptoms, and women with asthma
report poorer quality of life (37). This evidence supports the need for sex/gender-specific
exploration of symptom clusters and the symptom experience.
Since few Black females have been included in HF symptom cluster research, it is
first necessary to determine if it is feasible to recruit this population, explore if and what
barriers and facilitators to adequate recruitment exist, and determine participants'
willingness to participate in research studies (38). Qualitative methods are needed to
explore the intersection of gender, sex, and race and their impact on the symptom
experience, as quantitative instruments alone have limited ability in encompassing such
factors. Studying the symptom experience and symptom clusters concerning gender, sex,
race, and type of HF is warranted considering the increased burden of HF symptoms,
greater risk, and worst outcomes in females, Black Americans, and patients with HFpEF
(2, 4, 7, 8, 10).

Theoretical Framework
Many factors contribute to the health disparities and worse outcomes that are
evident for multiple conditions, such as societal and cultural stressors (7). The Symptom
Management Model (SMM), shown in Figure 1, highlights the multi-faceted nature and
complex interactions of symptom components (39). The six components that comprise
the SMM are symptom experience, components of symptom management strategies,
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outcomes and symptom status, person, environment, and health and illness (39). For this
study, symptom experience and person influenced the semi-structured interview guide, as
these components are well suited for individual interviews, best answer the overall
research question, and allow for exploration of demographic, psychological, and
sociological factors that can influence the symptom experience of a Black woman with
HFpEF (39). These components also guided content analysis of interview data and the
triangulation of questionnaire and interview results (39). The Minnesota Living with
Heart Failure Questionnaire (MLHFQ) is a quality-of-life questionnaire that was used to
collect quantitative data on physical symptoms, emotional symptoms, and quality of life
(40). These three domains of the MLHFQ also influenced interview guide questions,
which set the stage for merging of quantitative and qualitative results (40, 41).
Figure 1: Conceptual model of mixed methods feasibility study components within the
SMM Framework adapted by the author (38, 39, 40, 46, 48)
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Innovation
Current HF practice paradigms diagnose and treat males and females using the
same guidelines, despite growing evidence of sex differences in symptom expression,
disease burden, and quality of life (1, 2, 4-6). This study is innovative in that it sought to
shift this paradigm by emphasizing sex and race, which was consistently lacking in a
review of the literature (30). This was done by initially exploring the symptom
experience and symptom clusters for Black females with HFpEF using a mixed methods
research design.
The convergent mixed methods design is a novel approach to HF symptom cluster
research that, to our knowledge, has not been conducted before. Utilizing mixed methods
allowed for a more comprehensive exploration of the HF symptom experience and
symptom clusters for Black women. Symptom clusters are created based on data from
questionnaires, which have a limited ability in assessing personal factors and symptom
perceptions, evaluations, and responses. Individual, semi-structured interviews guided by
qualitative description allowed for a straight description of the symptom experience as
described by participants (42-45).
Examining study feasibility was needed for understanding the nuances of
recruitment and data collection within a population of Black females with HFpEF (38).
Also, the Symptom Status Questionnaire Heart Failure (SSQ-HF) had not been validated
in this population (38, 46). The SSQ-HF was used to assess the presence, frequency,
severity, and distress of physical HF symptoms (46). A review of HF symptom cluster
literature revealed that out of eight studies conducted in the U.S., five had >70% white
participants, and SSQ-HF has not been well validated in a Black population (24-26, 28-
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31, 36, 46). This study's findings can increase the population's inclusion in future
research, thus expanding the generalizability of HF symptom cluster research long-term.
The National Institute of Nursing Research (NINR) has highlighted symptom
cluster research as a critical component to advancing symptom science (21). This study
provides valuable insights for recruiting a high-risk and understudied population and
determining barriers to success for a mixed methods HF symptom cluster study. This
study can also improve research efforts for the health of women by considering sex and
gender influences, a specific goal of the 2019-2023 Trans-NIH Strategic Plan for
Women's Health Research (47).

Specific Aims and Brief Description of Manuscripts
There are three manuscripts included in this dissertation: (1) an integrative review
of heart failure symptom cluster studies; (2) an analysis of the feasibility and
acceptability of a mixed methods approach to ascertain symptom clusters in Black
women with HFpEF, with reporting of preliminary symptom cluster analysis findings;
and (3) a qualitative study examining the symptom experience of Black women with
HFpEF and integration of qualitative themes with quantitative symptom data. The aims
and a brief description of each manuscript are listed below.

Aim 1: To synthesize the current state of literature related to symptom clusters in heart
failure (HF) utilizing the Symptom Management Model (SMM) by Dodd et al., 2001
The first dissertation manuscript is a comprehensive review of HF symptom
cluster literature with the following stated purpose: to determine the current state of
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literature related to symptom clusters in HF using the SMM in order to discover themes
within each component of the model (39). The HF symptom experience is complex and
should be examined within multiple components to ensure a more comprehensive and
holistic understanding. The integrative review revealed that symptom clusters can be
useful in clinical practice for monitoring patients remotely; educating patients on selfmanagement and symptom surveillance; determining the risk of cardiac events,
hospitalization, morbidity, and mortality; and incorporating psychological symptoms (5,
8, 15-30).
The review also highlights how future research should further examine the effect
that social and physical environments have on HF symptoms, as the environment
component of the SMM was the least studied. Research on cultural and sex differences
related to symptom responses or impact should be conducted rather than only examining
if clusters are similar. The included study designs lacked any qualitative component. A
mixed methods or qualitative approach to symptom cluster research will result in a richer
description of the symptom experience and how each component impacts this experience.

Aim 2: To (1) explore the feasibility and acceptability of a convergent mixed methods
symptom cluster study with a population of Black females with HFpEF and (2) explore
preliminary HF symptom clusters of physical and psychological/emotional symptoms by
cluster analysis of data collected symptom questionnaire data
The second manuscript reports the feasibility and acceptability of the convergent
parallel mixed methods dissertation study that examined the symptom experience and
how symptoms cluster in Black females with HFpEF. The qualitative and quantitative
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data were collected in the same time frame with equal priority. This manuscript also
presents preliminary findings from a symptom cluster analysis for this population to
describe the symptom clustering technique and identify findings that could later be
explored with a larger sample size.
The PI obtained IRB approval (Pro00101261) and recruited participants (N=44)
from social media to complete screening and demographics questionnaires, the Single
Item Literacy Screener, the Minnesota Living with HF Questionnaire, Symptom Status
Questionnaire – HF, and Personal Health Questionnaire – 8 (40, 46, 48, 49). Participants
who were interested and consented (N=15) were interviewed about their symptom
experience using a semi-structured interview guide. Feasibility outcomes were tracked
and measured throughout the study and were analyzed using descriptive statistics (38).
An exploratory hierarchical cluster analysis of questionnaire data was conducted in SPSS
version 25 (SPSS Inc, Chicago, Illinois) to form preliminary clusters.
All feasibility benchmarks of consent rate, recruitment rate, interview interest
rate, survey completion rate, and feasibility and acceptability question scores were met
for the study, and participants positively rated acceptability of the study protocol. Three
symptom clusters were formed, which included a highly symptomatic cluster (which
reported a high proportion of physical and psychological symptoms), a mildly
symptomatic cluster (which reported a lower proportion of symptoms, especially less
psychological symptoms), and a psychologically symptomatic cluster (which reported
fewer physical symptoms but more psychological symptoms than the mildly symptomatic
cluster).
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Aim 3: To (1) describe the symptom experience of Black women with HFpEF using
qualitative descriptive methods and (2) to integrate qualitative themes and quantitative
symptom data to examine confirmation, expansion, and discordance of results
The third manuscript presents qualitative results and integrates quantitative
findings with identified qualitative themes from the convergent parallel mixed methods
study. Qualitative data were collected using individual, semi-structured interviews
(N=15) and were analyzed using NVivo 20.3 software (QSR International, Pty,
Doncaster, Australia). Analysis was guided by qualitative descriptive methods, and a
directed approach to content analysis was used with SMM components and MLHFQ
domains as broad code types to guide the development of sub-codes (39, 40, 42-45).
Interviews were transcribed and analyzed as they were collected using a constant
comparative method (42-45). For mixed methods analysis, quantitative and qualitative
data were each analyzed separately, and results were integrated into a joint display and
compared and contrasted to highlight confirmation, expansion, and discordance (41-45).
Qualitative themes emerged relating to the person and symptom experience. Black
women with HFpEF discussed interactions of physical and emotional symptoms, and
positive correlations between symptom scales supported this theme. Women reported
shortness of breath and chest pain causing worry and fears of death. Participants reported
feeling like a burden to others and hid or downplayed their symptoms. Reduced physical
functioning impacted family life, household chores, and the ability to work.
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Heart Failure Symptom Clusters: An Integrative Review
Abstract
Background: Patients with heart failure have difficulty recognizing and understanding
their symptoms, contributing to 4 out of 5 people with heart failure requiring
hospitalization each year in the U.S. Clustering symptoms have been proposed to help
patients and clinicians identify and manage heart failure symptoms.
Objectives: The purpose of this integrative review was to determine the current state of
literature related to symptom clusters in patients with heart failure using the Symptom
Management Model to discover themes within each component of the framework.
Methods: We systematically searched Scopus, ProQuest, and PubMed databases to
identify peer-reviewed, original research published in English between 2009 - August
2020. Search terms included "heart failure" AND "symptom cluster" OR "symptom
relationships." The Whittemore and Knafl (2005) methodological framework was used to
guide this integrative review.
Results: Twenty-nine manuscripts underwent full-text review, and 18 were deemed
eligible. Physical and emotional/psychological symptoms clustered together and
separately. Younger age, lower education level, and female sex corresponded with more
distress from symptom clusters. Clinicians can use symptom clusters for risk
assessment.
Conclusions: Symptom cluster data lacked racial diversity and minimally examined sex
differences. No studies were identified that used qualitative methods. Current evidence
supports the use of heart failure symptom clusters for patient education, selfmanagement, symptom surveillance, and risk assessment. Clinicians should especially
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consider emotional/psychological heart failure symptoms, which can be distressing and
associated with worse outcomes.

Tweetable abstract: Clinicians can use heart failure symptom clusters for risk
assessment, especially psychological symptoms associated with worse outcomes.

What is already known about the topic?
•

Heart failure is associated with a substantial symptom burden, affecting patients'
quality of life, functional status, and disease outcomes.

•

Patient misinterpretation or lack of knowledge related to symptoms contribute to
frequent hospitalizations from heart failure.

•

Clinicians typically assess for disease-specific individual symptoms rather than
clusters of symptoms.

What this paper adds
•

Heart failure symptom clusters exist, and physical and emotional/psychological
symptoms clustered together and separately.

•

Current evidence supports the use of heart failure symptom clusters for patient
education, self-management, symptom surveillance, and risk assessment, and
clinicians should especially consider emotional/psychological symptoms, which
can be distressing and associated with worse outcomes.

•

Symptom cluster studies lacked racial diversity, minimally examined sex
differences, and did not utilize qualitative methods.
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Background
Heart Failure (HF) is a prevalent issue in the United States (U.S.), with an estimated
6.2 million Americans living with this disease (Benjamin et al., 2019). HF is a complex
disease in which ventricular filling or ejection of blood is impaired due to structural
changes or decreased cardiac functioning (Yancy 2013). HF is the most common cause of
hospitalization for those over the age of 65, and 4 out of 5 people with HF require
hospitalization each year (Pedrotty & Jessup, 2015; Riegel et al., 2018). Frequent HF
hospitalizations are attributed to patient misinterpretation of, or lack of knowledge related
to, symptoms, due to the complexity of symptom interactions and inadequate patient
education tools, resulting in delays in seeking care and inadequate self-management
(Pedrotty & Jessup, 2015; Riegel et al., 2018).
HF is associated with a substantial symptom burden, affecting patients' quality of life,
functional status, and disease outcomes (Dodd, Miaskowski, & Lee, 2004; Moser et al.,
2014; Pedrotty & Jessup, 2015). Clinicians typically assess for disease-specific individual
symptoms; however, they could examine symptoms in clusters (Dodd et al., 2004; Moser
et al., 2014). A symptom cluster is when two or more symptoms co-occur in a disease
process (Denfeld, 2020). Symptoms can be a derivative of procedures, medications, or
the disease process itself (Dodd et al., 2004). Effectively utilizing symptom clusters in
clinical practice could result in targeted patient education, enhanced surveillance of
exacerbations, and improved health outcomes (Dodd et al., 2004; Moser et al., 2014).
The existence of symptom clusters has been explored in other chronic diseases such
as cancer, yet the concept is still relatively new and unrefined (Aktas, 2013). Based upon
preliminary database searching, it does not appear there is a large body of evidence for
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symptom clusters in HF. Therefore, the purpose of this integrative review is to determine
the current state of literature related to symptom clusters in HF using the Symptom
Management Model (SMM) to discover themes within each component of the model
(Dodd et al., 2001).

Theoretical Framework
Existing evidence about symptom clusters in people with HF will be synthesized
using the SMM, depicted in Figure 1 (Dodd et al., 2001). The SMM considers the
complex and multi-faceted nature of symptoms and can help identify which areas of
symptom management have been well described within the literature and which areas
need further exploration (Dodd et al., 2001). The SMM focuses on the three components
of symptom experience, management strategies, and outcomes. The three components of
the symptom experience include perception, evaluation, and response to symptoms.
Management strategies incorporate aspects of treatment decisions, such as when to begin
treatment and dosing. Outcomes incorporate various components of symptom status, such
as quality of life, morbidity, and mortality. Together, these three components encompass
the symptom experience and management as a whole (Dodd et al., 2001).
The SMM was revised in 2001 to include three nursing science domains: person,
health and illness, and environment (Dodd et al., 2001). The person domain allows for
examining demographic, psychosocial, sociological, physiological, and developmental
factors. The health and illness domain includes risk factors, health status, and disease and
injury. The environment domain considers the impact of physical, social, and cultural
environments, which affect symptom interpretation and treatment decisions.
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Figure 1
Modified SMM (Dodd et al., 2001)

Methods
The Whittemore and Knafl (2005) methodological framework was used to guide
this integrative review. A well-defined literature search was undertaken within Scopus,
ProQuest, and PubMed with the assistance of a medical reference librarian using the
search terms "heart failure" AND "symptom cluster" OR "symptom relationships." Peerreviewed, original research articles published in English between 2009 and August 2020
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were reviewed to exclude very outdated references while including the essential early HF
symptom cluster studies. The search yielded 88 results, as shown in the Prisma flow
diagram in figure 2 (Moher et al., 2009). Twenty-three manuscripts remained after
duplicates were removed, and titles and abstracts were screened to exclude manuscripts
that were not about HF symptom clusters or did not meet the inclusion criteria specified
previously. An additional six studies were identified through a review of references for a
total of 29 manuscripts. Ten of the 29 manuscripts were excluded for examining
symptom patterns or relationships rather than clustering, and one manuscript was
excluded for not being specific to people with HF. After exclusions, 18 manuscripts
remained for data analysis.
For data evaluation, study quality was assessed using the quantitative nonrandomized category of the Mixed Methods Appraisal Tool (MMAT) (Hong et al., 2018).
The quality criteria consisted of 7 items, and a "yes," "no," or "can't tell" was assigned to
each criterion and displayed in Table 1 (Hong et al., 2018). Manuscripts were analyzed
chronologically by year published, beginning with the oldest. Chronologically analyzing
the manuscripts allowed for an illustration of research progression over the previous ten
years and built a chain of evidence (Whittemore & Knafl, 2005). Data were extracted by
hand from manuscripts and organized in a literature table under the SMM components
(supplementary material table 1), allowing for systematic comparison. Similar findings
were clustered, and themes were identified to summarize and synthesize the evidence.
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Figure 2
Prisma Flow Diagram (Moher et al., 2009)

Results
Of the 18 included studies, nine were conducted in the U.S., two in the Netherlands,
two in Korea, one in Hong Kong, one in the United Kingdom, and one in Taiwan. Two
studies were conducted cross-culturally in the U.S. and Asia, and one of those studies
included European centers in the Netherlands and Sweden (Moser et al., 2014; Park &
Johantgen, 2017). There was a relatively even split of study designs with five cross-
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sectional studies, five prospective cohort studies, seven secondary data analyses, and one
cluster analysis pilot study, as shown in Table 1. Components of symptom management
and outcomes and symptom status were present in all the included studies, and two
studies addressed every component of the SMM (Huang et al., 2018; Son & Won, 2018).
Prominent results were categorized according to SMM components, beginning with
outcomes and symptom status to familiarize the reader with identified symptom clusters,
and then person, health and illness, symptom experience, and components of symptom
management strategies.

Table 1: Included studies, study info, Symptom Management Model components present
in each study, and Mixed Methods Appraisal Tool Methodological Quality Scoring
| Symptom Management Model Component (X=present) |
Year,
Author

Health
&
illness

Sympto
m
experien
ce

X

X

X

X

Study
info

Person

2009,
Jurgens

-Secondary data
analysis
-N=687
-6 sites
in the
U.S.

2009,
Jurgens

-Secondary data
analysis
-N=687
-6 sites
in the
U.S.

Environment
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Outcomes &
symptom
status

MMAT
scoring
(CT=
can’t
tell)

X

Components
of
symptom
management
X

X

X

X

X

S1:
YES
S2:
YES
3.1:
YES
3.2:
YES
3.3: CT
3.4:
YES
3.5: CT
S1:
YES
S2:
YES
3.1:
YES
3.2:
YES
3.3: CT
3.4:
YES

3.5: CT
2009,
Schiffer

-Prospective
cohort
-N=285
-The
Netherlands

X

X

X

2009,
Smith

-Prospective
cohort
-N=381
-The
Netherlands

X

X

X

X

X

2010,
Hertzog

-Cluster
analysis
pilot
study
-N=139
-Outpatient
HF clinic
in the
Midwest
U.S.

X

X

X

X

X

2010,
Lee

-Prospective
cohort
-N=331
-6
hospitals
in Kentucky,
Georgia,
and
Indiana

X

X

X

X

X

2010,
Song

-Prospective
cohort
-N=421

X

X

X

X
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S1:
YES
S2:
YES
3.1: CT
3.2:
YES
3.3: NO
3.4:
YES
3.5:
YES
S1:
YES
S2:
YES
3.1: CT
3.2:
YES
3.3: CT
3.4:
YES
3.5:
YES
S1:
YES
S2:
YES
3.1:
YES
3.2: CT
3.3:
YES
3.4: CT
3.5:
YES
S1:
YES
S2:
YES
3.1:
YES
3.2: CT
3.3: CT
3.4:
YES
3.5:
YES
S1:
YES
S2:
YES
3.1: CT

-2
tertiary
medical
centers in
Seoul,
Korea
2014,
Moser

2015,
Hawkins

-Crosssectional
observation
study
-N=720
-Asia
(China,
Taiwan),
Europe
(the
Netherlands,
Sweden),
and the
U.S.
-Prospective
cohort
-N=326
-Summa
Health
System
Ohio,
U.S.

X

X

X

2015,
Herr

-Crosssectional
-N=117
-U.S.
academic
medical
center

X

2015,
Lee

-Secondary data
analysis
of 2 prospective
cohort
studies

X

X
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X

X

X

X

X

X

X

X

X

3.2:
YES
3.3:
YES
3.4:
YES
3.5:
YES
S1:
YES
S2:
YES
3.1: CT
3.2:
YES
3.3: CT
3.4:
YES
3.5:
YES

S1:
YES
S2:
YES
3.1:
YES
3.2:
YES
3.3:
YES
3.4:
YES
3.5:
YES
S1:
YES
S2:
YES
3.1:
YES
3.2: CT
3.3: NO
3.4: CT
3.5:
YES
S1:
YES
S2:
YES
3.1:
YES
3.2: CT

2016,
Yu

-N=291
-HF
clinic in
Pacific
Northwest
-Secondary data
analysis
of a
crosssectional
study
-N=119
-Hospital
in Hong
Kong

2016,
Zhang

-Crosssectional
-N=1031
(626 with
confirmed
HF)
-United
Kingdom

2017,
Park

-Secondary
analysis
of a
crosssectional
study
-N=240
each
region
(480
total)
-U.S. and
Eastern
Asia
(Taiwan
and
China)
-Secondary data
cluster
analysis
of prospective
longitudinal
study

2018,
Huang

3.3: CT
3.4:
YES
3.5:
YES

X

X

X

X
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X

X

X

X

X

X

X

X

X

X

X

X

S1:
YES
S2:
YES
3.1: CT
3.2: CT
3.3:
YES
3.4:
YES
3.5:
YES
S1:
YES
S2:
YES
3.1: CT
3.2: CT
3.3: CT
3.4:
YES
3.5:
YES
S1:
YES
S2:
YES
3.1:
YES
3.2:
YES
3.3:
YES
3.4:
YES
3.5:
YES

S1:
YES
S2:
YES
3.1:
YES
3.2:
YES
3.3: CT

2018,
Son

2019,
Park

2019,
Salyer

2020,
Denfeld

-N=258
-4 HF
clinics in
Taiwan
-Crosssectional
-N=306
-Korea

-Secondary data
analysis
of HF repository
data
(intervention
and
crosssectional
studies)
-N=4,011
-U.S.
-Crosssectional
-N=117
-U.S.

-Secondary data
analysis
of 2
cohort
studies
-N= 274
-U.S.

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X
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3.4:
YES
3.5:
YES
S1:
YES
S2:
YES
3.1:
YES
3.2: NO
3.3:
YES
3.4:
YES
3.5:
YES
S1:
YES
S2:
YES
3.1:
YES
3.2: CT
3.3:
YES
3.4:
YES
3.5:
YES
S1:
YES
S2:
YES
3.1: CT
3.2:
YES
3.3:
YES
3.4:
YES
3.5:
YES
S1:
YES
S2:
YES
3.1: CT
3.2:
YES
3.3:
YES
3.4:
YES

3.5:
YES
*Mixed Methods Appraisal Tool (MMAT) Methodological Quality Criteria (Quantitative nonrandomized)
(Hong et al., 2018) S1. Are there clear research questions? S2. Do the collected data allow you to address
the research questions? 3.1. Are the participants representative of the target population? 3.2. Are
measurements appropriate regarding both the outcome and intervention (or exposure)? 3.3. Are there
complete outcome data? 3.4. Are the confounders accounted for in the design and analysis? 3.5. During the
study period, is the intervention administered (or exposure occurred) as intended?

Outcomes and Symptom Status
Outcomes and symptom status include functional status, emotions, costs, self-care
activities, quality of life, morbidity, co-morbidities, and mortality (Dodd et al., 2001).
Emotional, depressive, or psychological symptoms formed a cluster in 7 studies,
consisting of symptoms such as depression, worrying, anxiety, difficulty concentrating,
and poor self-esteem (Jurgens et al., 2009; Lee, 2010; Hawkins et al., 2015; Moser et al.,
2014; Schiffer et al., 2009; Smith et al., 2009; Zhang, Hobkirk, Carroll, Pellicori, Clark,
& Cleland, 2016). Three studies created somatic/affective and cognitive/affective
depression symptom clusters (Hawkins et al., 2015; Schiffer et al., 2009; Smith et al.,
2009). Psychological clusters were associated with memory and cognitive problems
(Hawkins et al., 2015; Jurgens et al., 2009; Lee, 2010). Psychological symptoms also
clustered with physical symptoms, including shortness of breath, daytime sleepiness, and
fatigue (Salyer et al., 2019; Yu, Chan, Leung, Hui, & Sit, 2016). A sickness behavior
cluster was found to significantly influence quality of life (b = - 0.603, p = 0.0001) and
accounted for 40% of its variance (F = 75.12, R2 = 0.404, p = 0.0001) (Salyer et al.,
2019).
For physical symptom clusters, shortness of breath clustered with fatigue with low
energy and increased need to rest, trouble sleeping, and difficulty walking or climbing in
three studies (Jurgens et al., 2009; Lee, 2010; Moser et al., 2014). Four studies found
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lower extremity edema or swelling did not fall within a symptom cluster (Lee, 2010;
Moser et al., 2014; Song, Moser, Rayens, & Lennie, 2010; Yu et al., 2016). A
gastrointestinal stress cluster was unique to three studies and included loss of appetite,
nausea, and decreased hunger (Herr et al., 2015; Salyer et al., 2019; Son & Won, 2018).
Six studies clustered participants by the symptom frequency, severity, and distress
they reported (Denfeld et al., 2020; Hertzog, Pozehl, & Duncan, 2010; Huang et al.,
2018; Lee, 2015; Park & Johantgen, 2017; Park et al., 2019). Creating clusters of
participants based on how they experienced symptoms rather than the symptoms
themselves allowed the authors to examine how symptoms may impact participants on an
individual level. For instance, Hertzog et al. (2010) found that clusters of participants
who reported fewer symptoms or less symptom impact were associated with fewer
physical and social limitations and better quality of life (all p < 0.001). Denfeld et al.
(2020) found that severe physical cluster participants were more likely to be in a severe
affective cluster.

Person
The person domain consists of demographics, psychosocial, sociological,
physiological, and developmental factors (Dodd et al., 2001). The studies in this review
predominately explored age, education level, and sex. Younger age was associated with
more psychological or emotional distress than older age, regardless of physical symptom
severity (Lee, 2010, Park et al., 2019). Park et al. (2019) found that for every 5-year age
increase, a patient with HF was 4.85 times less likely to be in the psychological distress
cluster (95% CI = [4.76, 4.95]) and 4.89 times less likely to be in the high physical and
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psychological distress cluster (95% CI= [4.82, 4.96]) (Park et al., 2019). Older
participants were also more likely to rate symptom severity that matched their
hemodynamic profile than younger participants (p= 0.003) (Lee et al., 2015).
Higher educational attainment was associated with inclusion in less severe
symptom clusters (Hertzog et al., 2010; Park et al., 2019; Smith et al., 2009; Son & Won,
2018). Participants with less than a high school degree were more likely to be in a
physical distress cluster (OR = 0.27; 95% CI = [0.16, 0.48]) and a high distress cluster
(OR = 0.16; 95% CI = [0.08, 0.33]) than those with at least some college (Park et al.,
2019). One study designed to study sex differences found that men and women had the
same symptom clusters, but women had significantly higher distress from their fatigue
symptoms and the increased need to rest, sleep disturbances, and feeling depressed than
men (Lee et al., 2010). Women also had significantly higher symptom distress scores for
a circulatory and GI symptom cluster (p< 0.001) and physical symptom cluster (p< 0.05)
than males in two other studies (Lee, 2010; Son & Won, 2018).

Health & Illness
The health and illness component addresses risk factors, health status, disease,
and illness (Dodd et al., 2001). Co-morbid conditions were the most prominent theme
found within the health and illness component. Jurgens et al. (2009) found diabetes to be
a predictor of inclusion in an emotional symptom cluster (Jurgens et al., 2009). Park et al.
(2019) found that participants with diabetes were also 1.91 times more likely to be in a
physical distress class (95% CI = [1.32, 2.75]) and 1.66 times more likely to be in a high
distress class (95% CI = [1.12, 2.46]) (Park et al., 2019). Participants with atrial
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fibrillation were 2.71 times more likely to be in a high distress class (95% CI = [1.85,
3.96]) and had significantly higher symptom scores for bodily pain and energy
insufficiency clusters (p=0.015) (Park et al., 2019; Son & Won, 2018). Participants with
hypertension were twice as likely to be in a high distress cluster than in a low distress
cluster (OR = 2.04; 95% CI = [1.38, 3.02]) (Park et al., 2019).
Multiple studies assessed the relationship between symptom distress and risk.
Findings from Jurgens et al. (2009) suggested distress from HF symptoms had little
association with degree or type of cardiac dysfunction (Jurgens et al., 2009. However,
Schiffer et al. (2009) found that distress from a cognitive/affective depressive symptom
cluster was a significant predictor of disease-specific health status (HR=2.3, 95% CI =
1.21-4.44, p=0.01) (Schiffer et al., 2009). Lee et al. (2015) discovered that total symptom
distress scores from an emotional/cognitive symptom cluster were an independent
predictor of cardiac event-free survival (HR=1.18; 95% CI, 1.03-1.37) (Lee et al., 2015).
Participants with severe symptom profiles were 3.3 times more likely to have a clinical
HF event, and those with high-severity dyspnea and fatigue had a significantly higher risk
for a cardiac event (p=0.016) (Huang et al., 2018; Lee, 2010). Inclusion in a
somatic/affective depressive symptom cluster predicted risk of mortality (HR=1.8, 95%
CI, 1.03-3.07, p=0.04).

Symptom Experience
Symptom experience incorporates how a person perceives, evaluates, and
responds to their symptoms. Manuscripts included in this review focused on symptom
distress, impact, and perceptions (Dodd et al., 2001).
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For symptom impact, an acute volume overload cluster high in shortness of breath
severity accounted for 45.7% of the variance in impact of symptoms on living as desired
(Jurgens et al., 2009). This finding coincides with results from a respiratory distress
cluster that accounted for 21.3% of the variance (21.3%) of symptom impact (Son &
Won, 2018). For symptom distress, lack of energy was the most distressful physical
symptom in one study, and orthopnea the least (Song et al., 2010). Although edema is a
common HF symptom, it was not particularly distressing to participants or sometimes
even noticed unless severe (Lee, 2010; Moser et al., 2014). Those with higher distress
from symptoms had a more significant co-morbidity burden (Lee et al., 2010). Distress
symptom clusters and functional limitation secondary to breathlessness were independent
predictors of quality of life (Yu et al., 2016; Zhang et al., 2016).
Components of symptom management strategies
Creating a symptom management plan includes encompassing the other SMM
components and considering them when making symptom management
recommendations (Dodd et al., 2001). Authors of the included studies suggested using
symptom clusters for patient monitoring, intervention development, patient education on
when to seek care, prognosis, proper medication management, and a better understanding
of the interplay between physical and psychological symptoms. Multiple studies
recommend using symptom clusters for monitoring patients with HF for exacerbations
(Huang et al., 2018; Jurgens et al., 2009; Moser et al., 2015; Park & Johantgen, 2017). It
has been noted that examining symptoms in clusters could improve surveillance of
symptoms and promote early detection of worsening symptoms, which is especially
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important considering the increasing utilization of telehealth monitoring without physical
assessment (Huang et al., 2018; Jurgens et al., 2009).
Clinicians and researchers can also use symptom clusters to develop interventions
that manage an entire cluster of symptoms (Herr et al., 2015; Lee, 2010; Park et al., 2019,
Yu et al., 2016). Yu et al. (2016) discussed how these targeted interventions could be
more beneficial than addressing symptoms individually due to the synergistic effect
clustered symptoms have of causing more distress when they are co-occurring (Yu et al.,
2016).
Symptom clusters can also be used as an educational tool to empower people with
HF to understand when to seek care and promote awareness of symptoms (Herr et al.,
2015; Jurgens et al., 2009; Lee et al., 2010; Moser et al., 2014; Son & Won, 2018; Song
et al., 2010). Only 9% of hospitalized patients with HF reported regular monitoring of
symptoms before hospitalization, and patients were less efficient at recognizing
symptoms when they gradually worsened over time (Song et al., 2010). Clinicians can
use symptom clusters to educate patients on alleviating symptoms and discussing
symptom management at discharge to reduce hospital re-admissions and decreased
functional status (Herr et al., 2015; Moser et al., 2014; Son & Won, 2018).

Discussion
The SMM highlights how symptoms have multi-faceted and complex interactions
with various components (Dodd et al., 2001). The results of the included symptom cluster
studies coincide with this theory. For instance, lower extremity edema was not clustered
with other symptoms in 4 studies and was often not noticed or distressing unless severe

34

(Lee et al., 2010; Moser et al., 2014; Song & Won, 2010; Yu et al., 2016). Suppose
patients are not feeling impacted by symptoms, such as lower extremity edema. In that
case, they may delay seeking treatment, as evidence suggests patients with HF are prone
to ignore or adapt to symptoms they do not consider significant (Jurgens et al., 2009).
Therefore, clinicians need to educate patients on the most concerning symptom clusters
that indicate worsening HF disease status.
An example is shortness of breath, a symptom linked to anxiety and depression in
a distress symptom cluster, which accounted for 21.3% of the variance in symptom
impact when included in a respiratory distress cluster (Son & Won, 2018; Yu et al.,
2016). Clinicians can educate patients on the most effective ways to monitor for shortness
of breath and the symptoms that cluster alongside it. This education could help patients
better recognize signs of impending HF exacerbation rather than attributing shortness of
breath to aging or other co-morbidities and not seeking help. Future research should
evaluate whether an educational tool for monitoring symptom clusters would be feasible
and beneficial (Song et al., 2010).
It is also important to note that none of the studies included in the review
contained a qualitative component, showing a significant gap in HF symptom cluster
research that future research should address. A qualitative component is needed to begin
a more in-depth, robust understanding of how people with HF perceive, interpret, and
respond to symptom clusters. Qualitative interviewing is especially warranted for
exploring psychological, emotional, and cognitive symptom clusters. The need for
clinicians to recognize such symptom clusters and expand assessments beyond physical
symptoms was the most prominent theme found within symptom management strategies.
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People with higher distress from emotional/cognitive symptoms may be at the highest
risk for adverse outcomes, especially younger people who report more distress (Herr et
al., 2015; Lee et al., 2010). At this time, the American College of Cardiology
Foundation/American Heart Association (ACCF/AHA) guidelines for the management of
HF do not propose strategies for addressing psychological symptoms (Lee et al., 2010;
Park et al., 2019; Yancy et al., 2013). The ACCF/AHA HF guidelines recognize
depression as a common co-morbidity in people with HF that can lead to poor self-care
behaviors, worse quality of life and disease outcomes, and the need for more frequent
medical services (Yancy et al., 2013). However, the guidelines state that an effective
intervention strategy for depressive symptoms is unknown (Yancy et al., 2013; Yancy et
al., 2017; Hollenberg et al., 2019). Clustering symptoms may help connect physical and
psychological symptoms for improved understanding and management of the disease
(Lee et al., 2015). Providers need to listen to how patients feel to assess the risk of
adverse events, as clinical data may not accurately reflect their risk alone (Lee et al.,
2015).
Of the 18 included studies, 14 had over 30% females in their sample. However,
sex differences were not addressed in depth. One study examined sex differences in
symptom clusters and found identical clusters, but women reported significantly higher
symptom distress from a physical symptom cluster (p< 0.05) than males (Lee et al.,
2015). This finding indicates that there can be variation in symptom response and the
impact the cluster has on quality of life. To further examine sex differences and enhance
data's robustness, future research should use qualitative methods to explore the higher
levels of symptom distress women experience.
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The environment domain was the most understudied. Three manuscripts
addressed culture, and none addressed social and physical environment. Son and Won
(2018) suggest using the ecological approach to explore differences in symptom clusters
across cultures, races, and locations. Park and Johantgen (2017) state that a mixedmethods study design could provide a more holistic depiction of cultural differences in
HF symptom clusters.
The MMAT was used to evaluate the included studies' methodological quality
(Hong et al., 2018). All of the studies met at least four of the seven criteria, and two
studies met all seven (Hawkins, 2015; Park, 2017). A lack of racial diversity for U.S.
studies was noted, with 6 out of 9 studies conducted within the U.S. having over 70%
White participants (Denfeld et al., 2020; Hawkins et al., 2015; Hertzog et al., 2010; Lee
et al., 2010; Lee et al., 2015; Park et al., 2019). Considering that Black Americans are 1.5
times more likely to develop HF than White Americans, diversity and inclusion in HF
symptom cluster research is imperative for generalizability to the U.S. population
(Parashar et al., 2009). Also, the studies used questionnaires such as the MLHFQ,
limiting the number of symptoms that participants can report to only symptoms that
appear on the questionnaire. Researchers can explore more symptoms with a qualitative
approach, which current HF symptom cluster studies currently lack.
This integrative review has some limitations. Only Scopus, ProQuest, and
PubMed were searched, and after exclusions, all included manuscripts were from Scopus.
Furthermore, alternate search terms could be added to find additional relevant
manuscripts.

37

Conclusion
The HF symptom experience is complex and should be examined within
multiple components to ensure a more comprehensive and holistic understanding. This
integrative review synthesized the most prominent themes from current HF symptom
cluster research. HF symptom clusters can be useful in clinical practice for determining
the risk of cardiac events, hospitalization, morbidity, and mortality. HF symptom
clusters that incorporate psychological symptoms are instrumental, as psychological
symptoms were often associated with increased risk. Clinicians should examine factors
related to the person alongside symptom clusters, especially regarding younger age.
Future research should further investigate the effect that social and physical
environments have on HF symptoms, as the environment was the least studied SMM
component. Future research should explore cultural and sex differences related to
symptom responses or impact. The included study designs lacked any qualitative
component. A mixed methods or qualitative approach to symptom cluster research will
result in a richer description of the symptom experience and how each component
impacts this experience.
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Supplementary Material Table 1: Integrative Review Literature Table with Data Organized within Each Symptom
Management Model Component
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experience
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symptom management
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appetite changes
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problems, psychomotor
retardation/ agitation, suicidal
ideation
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-age did not

Herr
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3 symptom clusters

account for
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-sickness behavior cluster:

variance in
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anxiety, depression, daytime

functional

discomforts of illness

sleepiness, cognitive
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clusters impact

dysfunction, fatigue

mobility

functional limitation and
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shortness of breath, lower

reported limitations with

extremity edema, pain

activities of daily living)

-gastrointestinal stress cluster:
loss of appetite and decreased
hunger
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-concordant

Lee

NONE

-severe symptom

-most adults with

-clustering may connect

3 symptom profiles

profile older

profile patients

HF do not have

biological with non-

-concordant symptoms:

(p=.003),

3.3 times more

concordant

biological symptoms for

moderate physical and

college

likely to have

symptoms and

improved understanding

psychological symptoms, good

educated

clinical HF event

hemodynamics

of symptoms and

hemodynamics (no mismatch,

management
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(39.2% vs
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13.5% severe

-poor

-symptom perception

-severe symptoms: worst

symptoms and

hemodynamics

important in risk-

symptoms, average

27.7% poor

profile 3.9% more

assessment

hemodynamics (mismatch,

hemodynamics

likely
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, p=.008)

-poor hemodynamics: worst
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symptom burden (mismatch,
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Yu

NONE
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-63.25% of

-managing entire cluster

3 symptom clusters

variance in

rather than individual

-distress cluster (shortness of

symptom experience

symptoms optimal

breath, anxiety, depression)

explained by 3

-need for palliative care

-decondition cluster (fatigue,

clusters, predict

interventions for

drowsiness, nausea, reduced

quality of life

symptom distress related

appetite)

-anxiety and

to advanced HF

-discomfort cluster (pain,

depression linked to

generalized discomfort)

shortness of breath

-Lower extremity edema and

in distress cluster

poor sleep quality were not
included in any clusters

52

2016,

NONE

NONE

Zhang

-symptom cluster

-Quality of life

-clinicians may be able

7 clusters

patterns similar

unlikely to be stable

to ask one question

-breathlessness

between those

over time

regarding quality of life

-psychological distress

with and without

-functional

to assess rather than

-sleep quality

HF

limitation secondary

using entire complicated

-frailty

to breathlessness is

questionnaire

-cognitive/psychomotor

key determinant of

function

quality of life

-respiratory system
-chest pain
-clusters accounted for 65% of
variance in quality of life

2017,
Park

NONE

-Taiwan/

NONE

-mean sums of

-clinicians may need to

U.S.- 4 clusters

China lower

Eastern Asia

consider culture when

-class 1: all mild (25%)

symptom

symptom distress

assessing symptom

-class 2: moderate physical

distress than

scores significantly

burden and providing

(33%)

U.S. in 6/8

lower than U.S. (all

education on symptom

-class 3: moderate

symptoms

p < .05)

self-management

psychological (7%)

-U.S. had

-class 4: all severe (36%)

clusters with

Eastern Asia- 3 clusters

differing

-class 1: all mild (41%)
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psych and

-class 2: all moderate (31%)

physical

-class 3: all severe (28%)

symptoms,
Asia did not
2018,
Huang

NONE

-14% Taiwan

-Left ventricular

-higher perceived

-determine how

3 symptom clusters

patients lived

dysfunction

anxiety = more

demographics affect

-non-severe cluster (all low

alone, more

present in 49% of

likely to be in

clusters for early

severity, n=191)

in typical

atypical cluster

typical cluster (OR

detection and diagnosis

-typical severity cluster (high

cluster (36%)

(p<.05)

= 1.23,

-pay attention to atypical

severity dyspnea/ fatigue, low

than non-

-more NYHA

p < .05)

physical symptoms since

for lower extremity edema,

severe (12%)

class III and IV in

-higher perceived

found to increase risk of

moderate others, n=28)

or atypical

non-symptom and

control = less likely

1-year cardiac events

-atypical severity cluster (low

(13%), p<.05

typical clusters

to be in typical

(HR 2.11, 95% CI [1.15,

severity dyspnea and fatigue

(>70%) than

cluster

3.88], p=.016)

(1.6 and 1.1), high for lower

atypical (28%)

(OR = 0.93,

extremity edema, moderate

-higher cardiac

p < .05)

others (1.9-3.7, n=39)

event rates for
typical cluster (p
= .016) and
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atypical (p=.001)
than non-severe
2018,

-Less educated

-author

-bodily pain and

-respiratory distress

-respiratory distress

3 symptom clusters identified

Son

had higher

proposes that

energy

cluster accounted

cluster could be an early

-respiratory distress cluster:

distress for

they are

insufficiency

for 21.3% variance

sign of worsening HF;

difficulty breathing while

clusters 2

filling a gap

cluster = strongest

of symptom impact

clinicians should educate

lying flat, shortness of breath

(p=.026) and 3

by examining

predictor of

-bodily pain cluster

on how to alleviate

at rest, waking up breathless at

(p=.022)

this

hospital

explained 18.86%

symptoms at home

night

-females

relationship

readmission

variance in distress

-highest readmission

-bodily pain and energy

higher distress

within the

(OR = 6.59, 95%

-circulatory/GI

from bodily pain cluster,

insufficiency: bodily pain,

(p<.001),

Korean

CI [1.29, 32.79])

cluster explained

patients may think these

fatigue, sleep disturbance

married
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Abstract
Background: Clustering symptoms and developing patient profiles could result in more
targeted and effective heart failure (HF) interventions down the line. However, Black
females remain significantly underrepresented in current HF symptom cluster research,
which also minimally examines sex differences and does not include qualitative
methodologies.
Objective: This manuscript evaluates the feasibility and acceptability of a study protocol
and procedures for a mixed methods approach to ascertain symptom clusters in Black
women with HF preserved ejection fraction (HFpEF). It then presents preliminary
symptom cluster analysis findings.
Methods: Participants recruited from social media completed screening and
demographics questionnaires, the Minnesota Living with HF Questionnaire, Symptom
Status Questionnaire – HF, and Personal Health Questionnaire – 8. Feasibility outcomes
were measured and analyzed, and a portion of participants were interviewed about their
symptoms.
Results: Forty-four Black women were enrolled in the study, with one of the 44
identifying as multiracial. The majority of the participants were married (45.5%) with a
mean age of 51.8 years. A hierarchical cluster analysis formed three clusters of
participants with statistically significant differences in the proportion of symptoms
experienced and co-morbidities. Cluster 1 was highly symptomatic with most participants
reporting most symptoms, cluster 2 reported fewer symptoms than cluster 1, especially
reporting less depressive symptoms, and cluster 3 reported mostly psychological
symptoms.
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Conclusions: The results of this study support the feasibility and acceptability of a mixed
methods protocol for studying symptom clusters in Black women with HFpEF. Symptom
clusters should be further explored with a larger sample.

Feasibility of a Mixed Methods Approach to Identifying Symptom Clusters in Black
Women with Heart Failure Preserved Ejection Fraction

Introduction
Heart Failure (HF) is a severe chronic disease that results in 30% of patients dying
within one year of diagnosis, and patients often suffering from prominent symptoms that
can impact physical functioning and health-related quality of life1-3-7. Heart Failure
preserved Ejection Fraction (HFpEF) is a specific type of HF caused by diastolic
dysfunction in which increased myocardial stiffness impairs relaxation of the left
ventricle8-9. A symptom cluster consists of two or more symptoms occurring
simultaneously in a disease10. Current evidence supports the existence and use of HF
symptom clusters and patient profiles to characterize which symptoms co-occur and
assess risk for adverse health outcomes4, 10-26.
Existing literature indicates that HF symptoms are especially burdensome to
females, who report more depression, worse symptom severity and quality of life, and
longer and more frequent hospitalization than males3-7. HF with preserved ejection
fraction (HFpEF) is more prevalent in females, by a factor of 2 in some studies2. Black
Americans are 1.5 times more likely to develop HF and have a 2.5 times greater risk of
dying from HF than White Americans27. Black adults in America are especially adversely
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affected by HFpEF, as they tend to be younger, have earlier onset, report worse QoL, and
have a greater risk of hospitalization than White Americans with HFpEF9.
Black women remain significantly underrepresented in current HF symptom
cluster research4, 10-26. Considering the increased burden of HF symptoms and overall
outcomes in women and Black Americans, studying the symptom experience and
symptom clusters concerning gender, sex, race, and type of HF is warranted3-7.
Furthermore, there are limited studies examining sex differences. To our knowledge,
there are no current HF symptom cluster studies that include qualitative methodologies4,
10-26

. Mixed methods and qualitative approaches to symptom cluster research are needed

to provide a richer description of the symptom cluster experience and the impact of sex
and race/ethnicity on this experience. To achieve this, Black women with HFpEF should
be recruited to share their symptom experience through surveys and interviews. However,
it is first necessary to determine the feasibility of recruiting Black women with HFpEF,
identify potential barriers and facilitators to adequate recruitment, and examine
acceptance of a study protocol28. Therefore, this manuscript reports the feasibility and
acceptability of a study protocol and procedures for a mixed methods approach to
ascertain symptom clusters in Black women with HFpEF. We also present preliminary
findings from symptom cluster analysis for this population to describe the symptom
clustering technique and preliminary findings that can later be explored with a larger
sample size.
Methods
Sample
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After institutional review board approval, participants were recruited through
social media using Facebook ads, posts within Facebook groups, and snowball sampling.
Respondents completed a screening survey to determine eligibility online in REDCap or
via phone. Participants were eligible if they were 35- to 74 years old, identified as a
Black female and woman, and had a self-reported diagnosis of HFpEF (with an ejection
fraction greater than or equal to 50%). Exclusion criteria consisted of self-reported cancer
or end-stage disease diagnosis (end-stage heart failure, renal disease, respiratory/lung
disorder, liver disease, or cancer), stroke or myocardial infarction in the last six months,
or a recent hospitalization within the previous four weeks. A sample size of 50 was
targeted for this study based on a pragmatic approach to determining the feasibility
sample size29.
Eligible participants gained access to the fully study survey in REDCap or could
call the PI to assist in completing the survey if needed. Instructions for completing the
survey were presented before the questionnaires, and participants consented to
participating in the research study by completing the survey. The symptom cluster survey
included a demographics questionnaire with a single item literacy screener (SILS)30, the
Minnesota Living with Heart Failure Questionnaire (MLHFQ)31, Symptom Status
Questionnaire - Heart Failure (SSQ-HF)32, Personal Health Questionnaire - 8 (PHQ-8)33,
and feasibility and acceptability questions.

Measures
Demographic data were collected using a combination of the screening
questionnaire and demographic questionnaire. Symptoms were measured using the
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MLHFQ31, SSQ-HF32, and PHQ-833. The first questionnaire, the MLHFQ, is a 21-item
quality-of-life questionnaire designed for patients with HF, that includes questions related
to the impact of physical symptoms, emotional/ psychological symptoms, and HF-related
activities on daily life31. Participants rate how much an item affected their life in the past
month, using a Likert scale of 0-5 ranging from 0 indicating none to 5 very much31. The
MLHFQ has excellent internal consistency with a Cronbach’s α usually ranging from
0.89-0.96 and has been used successfully in forming symptom clusters in multiple other
HF symptom cluster studies4, 10, 11-13, 15, 23, 25, 31. The MLHFQ is short, easy to administer,
validated for its psychometric properties, and has been used to assess quality of life in
Black Americans in HF clinical trials4,10, 11-13, 15, 23, 25, 31,34.
The second questionnaire, the SSQ-HF, measures the presence, frequency,
severity, and distress of 7 physical symptoms most commonly reported in HF (shortness
of breath during daytime, shortness of breath lying down, fatigue or lack of energy, chest
pain, leg or ankle swelling, difficulty sleeping, and dizziness or loss of balance) in the last
four weeks32. If a symptom is present, the respondent rates frequency, severity, and
distress using a Likert scale of 1-4, with 1 being the least and 4 being the most32.
Cronbach's α for the SSQ-HF is 0.80 and the instrument asks about symptoms in the last
four weeks, the same time frame as the MLHFQ31, 32.
The third questionnaire, the PHQ-8, asks respondents to rate the severity of eight
depressive symptoms from 0 (not at all) to 3 (nearly every day) over the past two
weeks33. This depressive symptom scale is widely used and has a Cronbach’s α of 0.8333.
Finally, the SILS was included to assess health literacy in the study population30.
The SILS has been validated for assessing the likelihood of low health literacy in a
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participant, with a score of >1 indicating a “positive” result for low health literacy30.
Participants were also asked eleven questions about feasibility and acceptability at the
end of the survey related to instructions, study processes, time, compensation, the
purpose of the study, and recommendation of the study to others. Feasibility and
acceptability questions were adapted from Orsmond & Cohn’s guiding questions for
feasibility studies35. Scores ranged from 1 (completely disagree) to 5 (completely agree)
with 5 being the optimal score.

Feasibility Outcomes
The feasibility of study processes, resources, and human and data management
were analyzed as the primary aim of this study28. Study process feasibility outcomes were
assessed by examining consent rate, recruitment rate, interview interest rate, survey
completion rate, and feasibility and acceptability question scores. The consent rate was
determined by calculating the percentage of eligible participants who consented by
completing the next survey after the eligibility survey, with a 90% consent rate as the
benchmark. The recruitment rate was assessed by calculating the percentage of
participant recruitment goal met for both the survey and interviews. A benchmark goal
was >85% of recruitment, with a recruitment goal of 50 survey participants and 15
interview participants. The interview interest rate was determined by calculating the
percentage of participants who indicated they were interested in being interviewed at the
end of the survey, with the goal interview interest rate of 30%. The percentage of
completed surveys without missing data was calculated by dividing the number of fully
complete surveys by the total number of surveys and multiplying by 100, with a
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benchmark goal of >85%. Feasibility and acceptability question scores were averaged,
with a goal average score of 4 or higher.
Resource feasibility outcomes were assessed by examining interview data
collection time and recruitment burden. The interview data collection time was assessed
by calculating the average interview duration and the range of interview times. The goal
interview duration was <60 minutes. For recruitment burden, we tracked time spent
recruiting for the survey and interviews and calculated an average time per week for
each. Recruitment time for the survey included writing and sharing posts in social media
groups, responding to potential participants and social media group admins via messages
or comments, and management of Facebook ads. Recruitment time for the interviews
included emailing and calling participants who indicated interest in being interviewed at
the end of the survey. This recruitment time also included time spent scheduling
interviews. The recruitment burden benchmark was an average of < 20 hours per week.
The feasibility of management outcomes was examined based on transcription
time, software reliability, and adverse patient events. Phone interviews were transcribed
using automated software for clear audio and dialects and a transcription service was
used when this was not the case. Transcripts were reviewed and edited word-for-word for
correctness. The time spent editing transcripts was tracked, with the goal of < 2 hours
spent per transcript. Major events related to issues with software and data management
platforms or adverse events during data collection were tracked, with a goal of no major
events.

Statistical Analysis of Symptom Clusters
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A hierarchical cluster analysis was performed in SPSS version 25 (SPSS Inc,
Chicago, Illinois) to explore preliminary symptom clusters of physical and
emotional/psychological symptoms included in the MLHFQ, SSQ-HF, and PHQ-83133,36,37

. The hierarchical cluster method is used to cluster variables (symptoms) or cases

(study participants) and allows the researcher to determine the optimal number of clusters
after conducting the analysis rather than a priori36,37. Hierarchical clustering creates
compact and homogeneous clusters and maximizes differences in clusters36,37. The three
main steps to hierarchical clustering are calculating distances between variables, linking
clusters, and determining the number of clusters based on dendrogram and agglomeration
schedule results37. Branches of the dendrogram are based on semi-partial r-squared
scores, and smaller branches signify more similar clusters37.
To standardize scoring for symptoms across the three different questionnaires,
variables were dichotomized to either yes, the symptom was present for any symptom
score other than 0, or no, the symptom was not present. First, a hierarchical cluster
analysis was attempted to cluster by symptoms utilizing Euclidean distance and Ward’s
method of clustering. Ward’s method is best for maximizing significant differences
between clusters by using the F value and forms more homogenous clusters close to
equal in size37. However, due to the small sample size and the dichotomized variables,
this method was not optimal for forming meaningful clusters. Therefore, we employed an
alternative strategy to clustering by participant rather than cluster, described by Hertzog
et al14. We used between-groups linkage method and simple-matching to calculate
distance, both of which better suit the small sample size14. After conducting the cluster
analysis, we reviewed the agglomeration schedule for the point at which coefficients
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began significantly decreasing. This drop occurred at stage 41 in the agglomeration
schedule. The number of stages, 41, was then subtracted from the total number of cases,
44, suggesting that a 3-cluster solution was optimal.
The clusters were then compared by demographic variables and symptom
presence. Comparisons were completed using one-way ANOVA for continuous data,
Kruskal-Wallis Test for interval level data, and Fisher’s exact test for nominal data, with
a significance level of .05 for all tests. Pair-wise comparisons were also completed for
Kruskal-Wallis tests using Dunn’s (1964) test with a Bonferroni correction within SPSS
(SPSS Inc, Chicago, Illinois).
Results
A total of 70 participants were deemed eligible from the screening questionnaire,
and of these, 67 participants completed the consent process and the survey. After a
review of data to remove participants who did not meet inclusion criteria based on
responses to the demographic questionnaire, 44 participants remained for analysis. All 44
participants (Table 1) identified as Black race, with one of the respondents also
identifying as White. The average participant age was 51.8 years old, with an age range
of 37 to 74. The majority of the participants were married (45.5%) or single (27.3%),
with an average of 2 children. Thirty-nine percent of women had a high school diploma
or GED, 18.2% reported no high school degree, and 43% of participants had an associate
degree or higher. The majority (77.3%) of participants reported “never” or “rarely”
needing someone to help them read written materials from their doctor or pharmacist in
response to the single item literacy screener30. The majority of participants were
diagnosed with HF in the last four years (88.6%), with 11.4% of participants diagnosed in
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the last five to eight years and no participants reporting a diagnosis for nine years or
longer. All participants had some type of insurance, with Medicare and Medicaid being
the most common (54.6%). Twenty-six of the 44 participants reported having one or
more co-morbidity, with hypertension (34.1%), respiratory diseases (31.8%), and atrial
fibrillation (27.3%) being the most commonly reported. Body Mass Index (BMI) was
calculated based on self-reported height and weight. The majority of the participants
(56.8%) were classified as having a “healthy” BMI within the range of 18.5-24.9, while 6
(13.6%) had an “overweight” BMI of 25-29.9, 11 (25%) were classified as “obese” with
a BMI greater than or equal to 30, and 2 were classified as “underweight” with a BMI
less than 18.538.

Feasibility
Analysis of study processes, resources, and management was conducted to
determine this study protocol’s feasibility28, as shown in table 2. Study process feasibility
results were as follows. The consent rate was 95.7% for the study. A total of 70
participants were recruited using social media over 5 weeks; 67 out of 70 consented to
participate in the study. Out of the 67 participants who completed the survey, 38 (56.7%)
were interested in being interviewed about their symptom experience. Of those 38, 15
were successfully interviewed, which satisfied 100% of the interview recruitment goal of
15 participants. The other participants who were not interviewed either did not respond to
the initial email invitation to be interviewed (N=14), stopped responding during interview
scheduling (N=6), or did not answer calls during their scheduled interview time (N=3).
Demographic questionnaires of the 67 participants who completed the study were
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reviewed to assess eligibility. Twenty-three participants out of 67 were excluded for ages
outside criteria (N=19) or not identifying as Black (N=4). Forty-four eligible participants
remained for analysis, resulting in 88% of the survey recruitment goal, which was above
the 85% benchmark. Out of the 44 included survey respondents, 43 (97.7%) surveys were
fully completed without missing data. The average rating across all feasibility and
acceptability questions was 4.87 out of 5, and no participants rated feasibility or
acceptability lower than a 3 (neither agree nor disagree).
Feasibility outcomes of resources were also examined to identify resources
needed to conduct the study on a larger scale. Data collection time for phone interviews
ranged from 18 to 55 minutes, with an average interview duration of 35 minutes. This
time frame only includes the interview, not quantitative survey completion that was
completed on REDCap. An average time of 14.4 hours was spent recruiting participants
over five weeks for the survey recruitment burden. Recruiting and scheduling participants
for interviews took, on average, 5.8 hours per week for 13 weeks. For management
feasibility outcomes, interview transcripts took less than two hours to edit for accuracy
with the assistance of transcription software. No significant events were reported with
software reliability or adverse patient events.

Cluster Analysis
A preliminary symptom cluster analysis was conducted with the feasibility study
sample to observe the hierarchical clustering technique and identify preliminary findings
that could later be explored with a larger sample. Clusters were formed by clustering
participants according to the number and types of symptoms reported. The agglomeration
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schedule was reviewed to determine the three-cluster solution. We then compared
clusters by presence of symptoms (figure 1 and table 3) and demographic variables by
cluster (table 4) to validate cluster differences.

Highly Symptomatic Cluster
Cluster 1, the highly symptomatic cluster, reported the most symptoms of the
clusters and contained the largest number of participants (26). Over 75% of participants
reported experiencing all symptoms except chest pain (65.4%) and dizziness (61.5%). All
participants (100%) reported feeling depressed and fatigued (need to rest), and 25 of 26
participants reported shortness of breath, lack of energy, leg swelling, and feeling bad
about themselves. The mean age in Cluster 1 was 50.3 years (SD=10.9), and the average
BMI was 25 (SD=5.8). Most of the participants in the highly symptomatic cluster
reported not having any comorbidities (57.7%). Of the comorbidities that were present,
hypertension (23.1%), atrial fibrillation (19.2%), and diabetes (15.4%) were the most
commonly reported.

Mildly Symptomatic Cluster
Cluster 2 was mildly symptomatic, as this cluster reported fewer symptoms than
cluster 1, especially regarding depressive symptoms. All participants reported a lack of
energy, and almost all (93.3%) reported shortness of breath, leg swelling, and fatigue or
need to rest. Otherwise, 33.3% of participants or less reported experiencing the rest of the
symptoms. Every participant in the study reported experiencing fatigue or need to rest
except one participant from this cluster. Cluster 2 was the 2nd largest cluster with 15
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participants, who were, on average, 54.1 years old (SD=12.5) with an average BMI of
29.6 (SD=20.9). The most commonly reported comorbidities in cluster 2 were atrial
fibrillation (46.7%), hypertension (40%), coronary artery disease (33.3%), and Chronic
Obstructive Respiratory Disease (33.3%), while 20% of participants reported not having
any comorbidities.

Psychologically Symptomatic Cluster
Cluster 3 reported few physical symptoms, considering the only physical symptom
these participants reported was fatigue (need to rest) (3/3, 100%), but this cluster reported
more psychological symptoms included in the PHQ-8, such as poor appetite (2/3, 66.6%),
feeling bad about themselves (2/3, 66.6%), trouble concentrating (1/3, 33.3%), feeling
depressed (1/3, 33.3%), and anhedonia, or inability to feel pleasure (1/3, 33.3%). This
psychologically symptomatic cluster was the smallest cluster, with only three
participants. The three participants had a mean age of 52.7 years (SD=2.5) and a BMI of
36.6 (SD=11.3). All 3 participants in this cluster reported comorbidities, with 2 (66.7%)
reporting diabetes, 2 (66.7%) reporting hyperlipidemia, and all (100%) reporting
hypertension.

Comparison of clusters
Clusters were compared according to demographics, comorbidities, and symptoms
experienced. No statistically significant differences were observed between clusters for
age (F (2, 41) = 0.574, p = .568)) or BMI (F (2, 41) = 1.332, p = .275)). For differences in
comorbidities, there were statistically significant differences in proportions of those who
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reported coronary artery disease (p=.049) and those who reported having no
comorbidities (p =.02) between the highly symptomatic and mildly symptomatic clusters.
The highly symptomatic cluster reported a statistically significant higher proportion of
psychological symptoms than the mildly symptomatic cluster (p <.001). Though not
found statistically significant, the highly symptomatic cluster was the most highly
educated group, with over 50% of participants having their bachelor's degree or higher.

Discussion
Results from this feasibility study are relevant for a variety of reasons. First,
almost all feasibility and acceptability benchmarks were met. Reaching these benchmarks
shows that Black females with HFpEF can be successfully recruited via social media for
an HF symptom cluster study and, just as importantly, they were satisfied with the study
protocol according to their positive responses to acceptability questions. Recruiting via
Facebook advertisements and snowball sampling is a viable method, as dynamic
Facebook ads can learn overtime who engages with the advertisement the most and
shows the ad to users like those individuals, thereby increasing potential reach. Access to
the survey link also allows participants to share the study with family members or friends
who may also be eligible for the study, further increasing the reach for participant
recruitment.
One barrier to reaching 50 participants for the study was having several
respondents who were not actually eligible once we analyzed their responses, especially
pertaining to age and race/ethnicity. This may have been due to errors while completing
the survey, such as a participant not checking Black for the race they identify with or

73

entering their age incorrectly. In the future, these factors should be analyzed in real-time
to allow for discussion with the participant to provide clarity and confirm eligibility. A
Facebook ad's benefit is that it enables the recruitment of a large number of participants
with minimal time and resources. The largest cost associated with recruiting individuals
was compensating them with a $25 Amazon gift card for completing the survey and
participating in an interview.
Though a hierarchical cluster analysis requires more than 44 participants for
statistically meaningful results, we conducted the cluster analysis to test the process and
develop preliminary clusters. The clusters formed in this study were similar to clusters
formed in the symptom cluster analysis completed by Hertzog, et al. in 2010, which used
similar methods. Comparison between clusters showed statistically significant differences
when compared to one another for the presence of almost all symptoms, which validates
the number of clusters chosen based on the agglomeration schedule. Interestingly, every
participant in the study reported experiencing fatigue (need to rest), except one
participant. Though the psychologically symptomatic cluster was small with only three
participants, the cluster showed prominent differences in symptoms experienced and
comorbidities, especially considering that almost all the symptoms experienced for this
cluster were psychological. Though no formal comparison was carried out due to the
small cluster size, the observed mean BMI for the psychologically symptomatic cluster
was 36.6 (SD=11.3) compared to 29.6 (SD=20.9) for the mildly symptomatic cluster and
25.0 (SD=5.8) for the highly symptomatic cluster. These characteristics should be
examined further in future larger studies.
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The highly symptomatic cluster had over half of participants reporting every
symptom. This group also had the youngest mean age, though not a statistically
significant difference. As the youngest and most symptomatic cluster, cluster participants
were also statistically significantly more educated than participants in the mildly
symptomatic cluster. HF symptom cluster literature has shown a relationship between
younger age and more distress from symptoms15, 17. This phenomenon should be more
closely explored in future larger samples. Qualitative data from interviews will also be
integrated with this symptom cluster data in a future manuscript to expand upon these
findings and further explain the symptom experience of Black women with HFpEF.
Though this study has a small sample size, the sample was adequate for assessing
feasibility and acceptability of the study protocol and allowed for the formation of
preliminary clusters of participants as a first step towards developing meaningful
symptom clusters for this population. Utilizing social media is a valuable resource for
reaching a large number of potential participants39. However, participants must be
properly screened to ensure accurate eligibility39. It is possible that respondents try to
gain access to the survey when they are not actually eligible because they did not
understand eligibility criteria, wanted to be included in the research, or for monetary
gain39. Extra measures were added to the survey to deter this from happening, such as
adding captchas, a test meant to distinguish humans from bots, screening for surveys
completed back-to-back with the same or very similar email addresses and requiring
participants to answer an attestation that they were answering questions truthfully39.
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Summary and Implications
The results of this study support the feasibility and acceptability of a mixed
methods study protocol for studying symptom clusters in Black women with HFpEF.
Preliminary clusters showed statistically significant differences in the proportion of
symptoms experienced and comorbidities. Cluster development and differences in
clusters should further be explored in a larger sample of participants adequate for
hierarchical cluster analysis.
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Tables:
Table 1: Study Sample Demographics
N=44

Frequency (Valid %)

DEMOGRAPHICS

Race/ethnicity
Black

44 (100%)

Single item literacy screener
Never

26 (59.1%)

Rarely

8 (18.2%)

Sometimes

5 (11.4%)

Often

5 (11.4%)

Always

0 (0%)

Education
No High School Diploma

8 (18.2%)

Diploma or GED

17 (38.6%)

Associate degree

3 (6.8%)

Bachelor’s Degree

7 (15.9)

Master’s Degree

7 (15.9%)

Doctoral Degree

2 (4.5%)

Current marital status
Single

12 (27.3%)

Married/ living with partner

20 (45.5%)

85

Mean (SD)

Separated

3 (6.8%)

Divorced

4 (9.1%)

Widowed

5 (11.4%)

Length of HF Diagnosis
0 – 12 months

11 (25%)

>1 year – 2 years

15 (34.1%)

3 years – 4 years

13 (29.5%)

5 years – 8 years

5 (11.4%)

Primary Insurance Status
None

0 (0%)

Medicare / Medicaid

24 (54.6%)

Public (marketplace)

7 (15.9%)

Private (employer)

10 (22.7%)

Other

3 (6.8%)

BMI Categories
Underweight (< 18.5)

2 (4.5%)

Healthy (18.5 – 24.9)

25 (56.8%)

Overweight (25 – 29.9)

6 (13.6%)

Obese (> 30)

11 (25%)

Age (years)

51.75 (11.1)

# of children

2 (range 0-8)

# people in household

3 (range 1-6)
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Table 2: Feasibility Outcomes

Feasibility
component

Indicator

Criteria

Outcome

Process
Consent rate

% of eligible

>90% consent rate

participants

67/70= 95.7 %
consented

consented by
completing next
survey
Recruitment

% of participant

>85% of recruitment

rate

recruitment goal goal (goal N=50 for

88% of survey
recruitment goal met

survey, goal N=15 for (N=67 recruited for
interview)

survey, 44 eligible for
analysis)

100% of interview
recruitment goal met
(N=15 for interview)
Interview

% of

>30% interview

38/67= 56.7 %

interest rate

participants

interest

interested in

interested in an

interview

interview
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Survey

% of completed

>85% fully

43/44= 97.7 %

completion

surveys

completed surveys

completed surveys

Feasibility /

Average scores

Average score of 4 or

4.87 average across

acceptability

ranging from 1-

higher

all feasibility /

scores

5

rate

acceptability
questions

Resources
Data collection Interview

< 60 minutes

Average interview

time -

duration

duration = 35 minutes

Interview

average

Interview duration
range 18 mins - 55
mins

Recruitment

Time spent with

< 20 hours

Questionnaire

burden

recruitment /

recruitment: 14.4

week

hours/week average
over 5 weeks

Interview
recruitment: 5.8
hours / week over 13
weeks

88

Management
Transcription

Time spent with

< 2 hours / interview

100% of interviews

editing time

editing

transcribed in <2

transcripts /

hours (with assistance

checking for

of software)

accuracy
Software

Issues with

reliability

software / data

No major events

None reported

No major events

None reported

management
platforms
Adverse

Adverse events

patient events

during data
collection

Table 3: Percent and frequency [% (n)] of symptom presence by cluster

SYMPTOM

SHORTNESS OF

HIGHLY
SYMPTOMATIC
CLUSTER
n=26

MILDLY
SYMPTOMATIC
CLUSTER
n=15

PSYCHOLOGICALLY
SYMPTOMATIC
CLUSTER
n=3

96.2 (25)

93.3 (14)

0

BREATH

89

pvalue*
.604

SHORTNESS OF

76.9 (20)

33.3 (5)

0

.008

LACK OF ENERGY

96.2 (25)

100 (15)

0

.634

CHEST PAIN

65.4 (17)

33.3 (5)

0

.048

LEG SWELLING

96.2 (25)

93.3 (14)

0

.604

DIFFICULTY

88.5 (23)

13.3 (2)

0

<.001

DIZZINESS

61.5 (16)

33.3 (5)

0

.078

FATIGUE NEED TO

100 (26)

93.3 (14)

100 (3)

.366

ANHEDONIA

88.5 (23)

13.3 (2)

33.3 (1)

<.001

FEELING

100 (26)

0

33.3

<.001

POOR APPETITE

88.5 (23)

33.3 (5)

66.6 (2)

<.001

FEELING BAD

96.2 (25)

0

66.6

<.001

80.8 (21)

13.3 (2)

33.3

<.001

76.9 (20)

0

0

<.001

BREATH LYING
DOWN

SLEEPING

REST

DEPRESSED

ABOUT SELF
TROUBLE
CONCENTRATING
SLOW OR RESTLESS

*p-value obtained from Fischer’s exact test (only clusters 1 and 2 were compared due to small
sample size of cluster 3)
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Table 4: Demographic variables by cluster
% By Cluster

VARIABLE

HIGHLY
SYMPTO
-MATIC
CLUSTE
R

n=26

MILDLY
SYMPTOMATIC
CLUSTER

n=15

PSYCHOLOGICALLY
SYMPTOMATIC
CLUSTER

p-value*

n=3

HYPERTENSION

23.1

40

100

.21

HYPERLIPIDEMIA

11.5

26.7

66.7

.21

DIABETES

15.4

6.7

66.7

.39

ATRIAL

19.2

46.7

0

.07

7.7

33.3

0

.049

ASTHMA

7.7

6.7

0

.70

CHRONIC

11.5

33.3

0

.10

3.8

3.0

0

.30

NONE

57.7

20

0

.02

AGE (Y), MEAN

50.3

54.1 (12.5)

52.7 (2.5)

.57

29.6 (20.9)

36.6 (11.3)

.28

FIBRILLATION
CORONARY
ARTERY DISEASE

OBSTRUCTIVE
PULMONARY
DISEASE
OBSTRUCTIVE
SLEEP APNEA

(SD)
BMI, MEAN (SD)

(10.9)
25.0 (5.8)
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*p-value obtained from Fischer’s exact test (only clusters 1 and 2 were compared due to small
sample size of cluster 3) or one-way ANOVA

Figures:
Figure 1: Proportion experiencing symptom by cluster
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Abstract
Background: Black women with Heart Failure preserved Ejection Fraction (HFpEF)
have an increased burden of symptoms and worse health outcomes than White patients
with HF.
Objective: The purpose of this study was to characterize the symptom experience of
Black women with HFpEF and to integrate qualitative themes and quantitative symptom
data to examine confirmation, expansion, and discordance of results.
Methods: Using a convergent-parallel mixed methods design, a purposive sample of 44
Black women who were 35 – 74 years old with HFpEF were recruited using social media.
Quantitative data including demographics, Single Item Literacy Screener (SILS),
Minnesota Living with HF Questionnaire (MLHFQ), Symptom Status Questionnaire –
HF (SSQ-HF), and Personal Health Questionnaire – 8 (PHQ-8) were collected through
online surveys (N=44). Qualitative interviews were conducted to explore the background
and symptom experience of 15 participants. We used a directed approach to content
analysis and qualitative descriptive methods to analyze interview data, and descriptive
statistics and Pearson correlation to analyze quantitative data. The Symptom
Management Model (SMM) guided content analysis of interview data and integration of
data, in which findings from both qualitative and quantitative analyses were merged,
compared and contrasted.
Results: Ten themes emerged relating to the person and symptom experience.
Participants had an average MLHFQ quality of life score of 64.1 out of 105 and 45.5% of
participants had scores that indicated major depression on the PHQ-8.
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Conclusions: Black women with HFpEF discussed interactions of physical and
emotional symptoms. Positive correlations between symptom scales supported this
theme. Women reported shortness of breath and chest pain causing worry and fears of
death. Participants reported feeling like a burden to others and hid or downplayed their
symptoms. Reduced physical functioning impacted family life, household chores, and the
ability to work.

Qualitative and Integrated Results from A Mixed Methods Approach to Symptom
Clusters in Black Women with Heart Failure Preserved Ejection Fraction

Background
Patients with heart failure (HF) have a complex and multi-factorial symptom
experience that makes symptom self-monitoring and self-management challenging1-5.
Four out of five patients with HF are hospitalized each year with exacerbations that could
be avoided with early detection1. Females experience worse quality of life (QoL) and
functional impairment, and have higher rates of edema, depression, exercise intolerance,
and dyspnea on exertion compared to males3,4. Little is known about the symptom
experience in patients with HF preserved ejection fraction (HFpEF), a type of HF caused
by diastolic dysfunction in which relaxation of the left ventricle is impaired from
increased stiffness6,7. Black patients with HFpEF tend to be younger, report worse QoL,
and have a greater risk of hospitalization than White patients7. A better understanding of
symptoms and symptom experiences in this population may inform approaches to care to
improve outcomes.
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Qualitative studies are needed to explore how gender, sex, and race interact and
impact the symptom experience, as quantitative instruments alone have limited ability in
encompassing such factors. Considering the increased burden of HF symptoms, greater
risk, and worse outcomes in females, Black Americans, and patients with HFpEF1,6-8, this
study seeks to illuminate the experiences of those who are underdiagnosed, undertreated
and have a greater symptom burden3,4. A convergent mixed methods approach allows for
a more comprehensive examination of the HF symptom experience by integrating
qualitative interview data with quantitative symptom data to examine results for
confirmation, expansion, and discordance. Thus, the objective of this study was to
characterize the symptom experience of Black women with HFpEF and how symptoms
affect their life by presenting qualitative themes within the framework of the Symptom
Management Model. The integration of qualitative themes with corresponding
quantitative symptom scale data will be presented in a joint display and results will be
compared and contrasted to examine for convergence, discordance, and expansion.

Methods
A convergent-parallel mixed methods feasibility design was used to collect
qualitative and quantitative data in the same time frame with equal priority. Qualitative
data were collected using individual, semi-structured interviews with 15 participants.
Quantitative data were collected through online surveys using questionnaires and wellvalidated symptom scales. The study survey consisted of a demographics questionnaire
with a single item literacy screener9, the Minnesota Living with Heart Failure
Questionnaire (MLHFQ)10, Symptom Status Questionnaire - Heart Failure (SSQ-HF)11,
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Personal Health Questionnaire - 8 (PHQ-8)12, and feasibility and acceptability questions.
Each type of data was analyzed separately, results were integrated in a joint display, and
common concepts were compared and contrasted. Details of the feasibility study and
quantitative symptom cluster results are reported in a previous manuscript8.

Sample and setting
Following institutional review board approval (Pro00101261), a purposive sample
of participants was recruited using Facebook ads and posts within Facebook groups, and
snowball sampling by allowing participants to share the link with others who may qualify
for the study. Participants responded to a screening survey to determine if they fit the
eligibility criteria of a 35- to 74-year-old Black female who identified as a woman and
had a self-reported diagnosis of HFpEF (with an ejection fraction greater than or equal to
50%). Participants were not eligible if they reported having cancer or an end-stage
disease diagnosis (end-stage heart failure, renal disease, respiratory/lung disorder, liver
disease, or cancer), stroke or myocardial infarction in the last six months, or a recent
hospitalization within the previous four weeks. At the end of the quantitative survey,
participants were asked if they were interested in being interviewed about their symptom
experience and their preferred contact method. All participants who were interested in
being interviewed (n=38) were contacted via email or phone to schedule individual, semistructured interviews. We conducted interviews with all participants who responded and
consented to an interview, resulting in 15 interview participants.

Theoretical Framework
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The Symptom Management Model (SMM) highlights the multi-faceted nature
and complex interactions of symptom components13. Six components comprise the
SMM,13 symptom experience, components of symptom management strategies, outcomes
and symptom status, person, environment, and health and illness. For this study,
symptom experience and person influenced the semi-structured interview guide, as these
components are well suited for individual interviews, best answered the overall research
question, and allowed for exploration of demographic, psychological, and sociological
factors that can influence the symptom experience of a Black woman with HFpEF13.
These components guided content analysis of interview data and the integration of
questionnaire and interview results13,14. The three domains of the MLHFQ (physical
symptoms, emotional symptoms, and QoL)10 also influenced interview guide questions,
which set the stage for the merging of quantitative and qualitative results14, 15. Table 1
shows the merging of qualitative and quantitative data collection instruments within the
SMM framework.

Qualitative data collection
A semi-structured interview guide was developed to facilitate consistency in data
collection while allowing for unanticipated responses and was reviewed by industry
experts for completeness and clarity. Our team created open-ended questions about the
SMM13 components of symptom experience (perception, evaluation, and response) and
person, and the domains of the MLHFQ10 (physical symptoms, emotional symptoms, and
quality of life) about each participant and their symptom experience. Participants were
given the option to conduct interviews either over the phone or via virtual
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videoconference. One participant requested a videoconference, and all other participants
requested to conduct interviews via telephone, either due to technological capabilities or
personal preference.
Participants were asked to discuss their background and to describe their
symptoms in the last 4 weeks to correspond with the MLHFQ and SSQ-HF symptom
recall time frame10. Probes, both questioning and silent, were used to facilitate thoughtful
responses from participants16. Mirroring was utilized to ensure the PI was capturing the
true perspective of each participant by repeating phrases and ideas back to the participant
for confirmation of what they meant by their statements16. Each interview lasted on
average 35 minutes, with times ranging from 18 minutes to 55 minutes.

Qualitative data analysis
Interviews were audio recorded, transcribed verbatim using a professional
transcription service, and all transcripts were checked for accuracy. Transcripts were
coded with NVivo 13 software (QSR International, Pty, Doncaster, Australia) and
qualitative description was used to guide analysis of semi-structured interview data37-39.
This methodology is data near, meaning it aims to capture the true experience of
individuals by keeping analysis close to the given data rather than significantly
transforming data17-19. Interviews were transcribed and analyzed as they were collected
using a constant comparative method16. A directed approach to content analysis was used
with SMM13 components and MLHFQ10 domains as broad code types developed a priori,
which guided development of sub-codes19.

99

The PI initially performed level 1 coding before coding data within a priori
codes19. This first step was meant to increase trustworthiness by not allowing broad code
structures to result in missing important findings that did not fit within the selected
frameworks19. Two to three transcripts were analyzed at a time. Codes and emerging
themes were then reviewed with the research team qualitative expert and the HF content
expert, and codes were revised as needed16. Themes emerged from within and across
coding categories.
The research team qualitative expert oversaw coding of all interview transcripts
and debriefing occurred at each stage of the data analysis process to increase
transparency of coding and allow for triangulation of findings to increase credibility16. A
detailed audit trail was maintained throughout data collection and analysis to support
dependability16. All codes were developed by the 9th interview, and saturation occurred
after the 13th interview was analyzed, in which responses coincided with already
developed themes without adding new or differing information20.

Quantitative Data Collection and Analysis
We collected data on demographics, quality of life, physical symptoms, and
emotional / psychological symptoms using well-validated instruments, described in detail
in another manuscript8. Quantitative data were analyzed for standard descriptive
statistics, including medians, ranges, means and standard deviations. We examined the
relationship between questionnaire scores using a Pearson correlation analysis after
assessing normality using the Shapiro-Wilk's test.
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Mixed Methods Integration Analysis
Qualitative and quantitative data were integrated through methods, interpretation,
and reporting. In the methods stage, we merged qualitative and quantitative data
collection instruments within the SMM13 to better facilitate integration, as shown in
Table 1. Qualitative and quantitative data collection were conducted concurrently, and
each type of data was analyzed separately in parallel.
Once data analysis was complete and themes were identified from qualitative
data, we interpreted and reported both types of data using a joint display to integrate
results (Table 3). The first column of the joint display shows themes that were identified
from qualitative data analysis. The themes are organized within the SMM13 framework,
arranged by the headings of perception, evaluation, response, and person. The 2nd column
of the joint display contains quotes from interviews that relate to each theme for
participant contextualization, and the 3rd column shows quantitative data that corresponds
to each qualitative theme. We then integrated these data through the narrative below by
discussing data confirmation, expansion, and discordance.

Results
Qualitative Results
We reached out to all participants who indicated they were willing to participate in
an interview (N=38), and those who were not interviewed (23/38) either did not respond
to initial calls and emails for scheduling or did not answer during their scheduled
interview times. If participants did not answer during their scheduled time, the PI
attempted to reach out again via email and another phone call until there was no response
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from the participant. The demographics for interview participants (n=15) are presented in
Table 2. The average age of interviewees was 46.9 years (range 37-60). All participants
reported having children, with an average of 3 children, and the average number of
household members was four. Most (12/15) of the participants were married or living
with a partner, and 3 were single. Five participants did not have a high school degree, 5
had a high school degree or GED, 1 had some college, and 4 had a bachelor's degree.
Four of the participants currently worked as a teacher, baker, hairdresser, and
receptionist, with 11 reporting not having a job or not working right now.
Ten themes emerged from qualitative interviews related to symptom perception,
evaluation, response, and person. Themes were organized according to the SMM13
framework, as shown in Table 3, and are described below.
Emotional symptoms co-occurring with physical symptoms
Participants often described that their physical and emotional symptoms either cooccurred or interacted with each other. One participant reported that their emotional
symptoms impacted their physical symptoms by stating, "Sometimes when… sometimes
I become depressed. And the moment I become depressed and start thinking about my
condition too much, I find that I start experiencing (physical) symptoms". Feeling worry,
sadness, and fear along with physical symptoms was discussed in interviews.

Shortness of breath, fatigue, dizziness, and chest pain occurring together and leg or
ankle swelling occurring alone
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Participants reported that shortness of breath, fatigue, dizziness, and chest pain
co-occurred or caused one another. Participants described this by stating, "The shortness
of breath and fatigue and tiredness, that all happens at once", and "Dizziness comes from
the shortness of breath". This was especially the case for shortness of breath and fatigue.
Participants also discussed how leg or ankle swelling happened alone or separate
from other symptoms. Though a common symptom mentioned in interviews, participants
rarely associated feeling swelling with other symptoms.

Shortness of breath and chest pain causing fear, worry, and fears of death
When participants were asked how experiencing their symptoms made them feel,
they reported feelings of fear, worry, and fear of death when experiencing shortness of
breath and chest pain. One participant described why these two symptoms make her feel
this way by stating, "At times with the dizziness, with shortness of breath, fear can kick
in because you never know when the day is going to be your day. And by that, I mean
that you say goodbye to this Earth or that you may check in to the hospital."

Feeling like a burden to others
Women also reported feeling like a burden to others when they were experiencing
symptoms, such as in the quote, "Sometimes that it also makes... it can make me feel like
a burden because you're supposed to take care of your children, not your children take
care of you." Eight participants explicitly discussed feeling like a burden for needing help
with physical tasks and needing emotional support. Feeling like a burden was often
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paired with another feeling that others were pitying or judging them when they were
suffering from symptoms.

Daily life affected by physical functioning
For symptom evaluation, we identified the theme that daily life was affected by
activity level and physical functioning. In interviews, all participants discussed their daily
life being affected by decreased physical functioning. They often discussed difficulty
leaving the house and completing tasks around the house. One participant stated, "Even
with my walker, I'm not going to get there. I mean, I can tell myself. And then, to myself,
I'm saying, I'm going to go. And I wouldn't get to the driveway. So, I've got to go back to
the house."

Feelings of missing out
The feelings of missing out, either from not being able to do things with friends or
family or not being able to eat the types of food they used to enjoy, was a common theme
in interviews, in which 11 participants discussed these feelings. One participant described
this as "That I'm not experiencing the world at its fullest, you know? And when I do go
out, and I get out there, I'm like a kid in a candy store. I want to see everything, but I just
can't." Some participants also discussed how it was difficult being around others while
they were eating the food they used to be able to enjoy but no longer can.

Reducing activity level
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The most prominent symptom response was reduction of activity level, which all
interview participants reported. Participants reported that they would "rest," "lay down,"
or "just relax" if they were experiencing symptoms. Nine participants described how
overexerting or overworking themselves caused their symptoms to occur or become more
severe.

Not sharing feelings or downplaying symptoms
The theme emerged that participants often downplayed their symptoms or did not
share what they were experiencing with others. Ten interview participants discussed
hiding or downplaying their symptoms, mostly around their children, extended family,
friends, and co-workers. One participant stated, "But that can be real frightening,
especially if it happens and if the children sitting around and they're like, 'What's wrong?'
And you try to play it off to them like you're okay. But you know you're not, but you still
got to try to look okay, at least for them, so you're not instilling fear into them." All
participants reported not hiding their symptoms from nurses or doctors. One participant
described hiding things from their healthcare team as "self-defeating."

Inability to work or difficulty working due to symptoms
For the person component, we identified the theme that symptoms made working
difficult. Most interview participants (11) reported not currently working or having a job.
Out of those 11, 1 was retired, 4 were stay-at-home moms or homemakers, and 6 reported
not working because of their heart condition. One participant stated, "And I've worked
most of my life, but I haven't worked in the last three years because of my heart." The 4
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participants with a job reported missing work or not being able to do as much at work due
to symptoms, and one even mentioned how she had been thinking of quitting her job due
to her symptoms.

Support
We also identified the theme of support. Most participants reported having
support from their significant other, family, or religion. Twelve out of fifteen interview
participants (80%) were married or living with a partner, with 10 of those participants
saying they found support in that person. Seven interview participants said their support
system came from their children or other family members. The two participants who
discussed not having a support system in family or friends said they leaned on their
religion or God for support. Some discussed how difficult it is to share how they feel with
their support person. One participant described this as "Yes. And then I have them, but
sometimes we build up these walls. So, I would say they can support me for as long as I
allow them to support me. Because as soon as I quit expressing how I'm feeling, then
they're under the assumption that I'm okay."

Quantitative Results
Quantitative survey respondents (N=44) had mean total quality of life score from
the MLHFQ of 64.1 (9.4), and values ranged from 21 to 95, with 105 being the highest
possible score, as shown in Table 4. A higher score indicates more of an impact from HF.
The average total SSQ-HF score was 39.2 (16.0), and scores ranged from 0 to 68. A score
of 84 is the highest possible on the SSQ-HF and indicates more severe physical HF
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symptoms. The mean PHQ-8 score was 9.0 (6.2) and ranged from 0 to 24, where 24 is the
highest possible score indicating more depressive symptoms. Any score greater than 10 is
considered major depression, and any score greater than 20 is considered severe
depression. In the sample, 45.5% of participants had a score of 10 or higher, and 2
participants had a score of 20 or higher.
The Shapiro-Wilk's test showed scores were normally distributed for MLHFQ and
PHQ-8 scores (p > .05), but not for SSQ-HF scores (p < .05). Therefore, Spearman
correlation was used to assess the relationship between symptom scales. A strong positive
correlation was found between MLHFQ scores and SSQ-HF scores (r=.61, p < .01), and
moderate positive correlations were found between the PHQ-8 and MLHFQ (r=.48, p <
.01) and the PHQ-8 and SSQ-HF (r=.42, p < .01), indicating that as scores for one
questionnaire increase, so do scores for the others.
Integrated results
We integrated qualitative themes with quantitative data to gain additional insights
on the symptom experience and examine how results converged or diverged. There was
concordance between quantitative data and the theme of emotional/psychological and
physical symptoms co-occurring. All survey participants, except one, reported
experiencing worry and physical symptoms and rated worry as very impactful with an
average score of 4 and a median score of 5. Moderate to strong correlations were found
between the three scales, which measured different types of symptoms. Forty-six percent
of the sample had PHQ-8 scores that indicated major depression.
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The theme that shortness of breath, fatigue, dizziness, and chest pain co-occurred
aligned with quantitative symptom data. Thirty-nine out of 44 survey participants
reported shortness of breath, and 38 of those participants (97%) also reported fatigue.
Twenty-two out of 44 participants reported chest pain, with 15 of those participants
(68%) also reporting dizziness. Out of the entire study sample, participants (30%)
reported experiencing all symptoms of shortness of breath, fatigue, dizziness, and chest
pain. Leg and ankle swelling was a common symptom reported by 14 out of 15 interview
participants and 89% of survey participants. Interview participants discussed that
swelling occurred separately from other symptoms. This phenomenon could not be
confirmed with quantitative data, as participants were stating whether they experienced a
symptom in a certain time frame, not which symptoms actually showed up together.
Participants reported that swelling frequently occurred, with most participants (67%)
experiencing it 3 times a week or more. However, most participants did not find swelling
to be severe or more than somewhat distressful.
In interviews, shortness of breath and chest pain were described as distressful to
participants and were often accompanied by fears of death. However, there was
discordance between these feelings and quantitative scores. Average distress scores from
chest pain (1.91) were very similar to distress scores from swelling (1.95), where 4 is the
highest on the scale. Shortness of breath was slightly more distressful, with an average
score of 2.44. Participants reported in both interviews and surveys that overall, symptoms
made them feel like a burden to their family and friends. The median score for the
MLHFQ item of feeling like a burden was 3.5, with 50% of participants rating feeling
like a burden as a 4 or 5.
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MLHFQ item scores confirmed the qualitative theme of daily life being affected
by physical functioning. Every survey participant reported experiencing difficulty
working around the house or yard, with a mean impact score of 3.2 (1.5). All survey
participants except one reported experiencing difficulty going places away from home,
with a mean impact score of 3.25 (1.5). These scores coincide with interview findings,
where all participants discussed their daily life being affected by them having to keep
their activity levels low or decreased physical functioning. They often discussed
hardships related to leaving the house and difficulty completing tasks around the house.
MLHFQ responses also confirmed the theme of feelings of missing out on doing things
with friends and family, which all survey participants experienced.
The MLHFQ scores for lying down or resting during the day confirmed interview
findings that rest was the most common response to experiencing symptoms, as every
interview participant discussed. The MLHFQ item showed how much this impacts
participants, considering the average score of 3.5 and median score of 4. Survey
participants indicated that their HF made it difficult to work or earn a living according to
the MLHFQ item, a prominent interview theme. The majority of survey respondents
(52%) rated the MLHFQ item of making your working to earn a living difficult as a 5,
very much, making the median score a 5 and the average a 3.5. These high scores
coincide with interview findings, as even those who were able to work reported some
difficulty with their current jobs.
Discussion
Examining symptom data with a convergent mixed methods design allowed us to
identify several prominent findings, including the theme of perceptions that physical and
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emotional symptoms interact. Symptom clusters, created using symptom scales, show
when participants are experiencing symptoms together or at the same time. With the
qualitative interview, we know that some participants believe that their physical
symptoms actually trigger their emotional symptoms, or vice versa. This concept should
be explored further in future studies, as this could add valuable information about how
symptoms cluster. Moderate to strong correlations were found between symptom scale
total scores, though the sample was small.
During interviews, participants seemed to create their own symptom clusters of
how they believed their symptoms occurred together or interacted. Participants
commonly associated shortness of breath, fatigue, dizziness, and chest pain together.
Shortness of breath clustering with fatigue has been shown in other HF symptom cluster
studies2,21,22, which is consistent with our findings of 97% of participants reporting
shortness of breath along with fatigue. These were two of the most commonly reported
symptoms in this study. In the future, the interactions of these symptoms with one
another should be more robustly explored.
The participants also noted that leg and ankle swelling often happened alone. This
was also information that we exclusively gained from interviews, as the quantitative data
simply showed that 89% of participants experienced leg or ankle swelling along with
their other reported symptoms. Four other HF symptom cluster studies have found that
lower extremity edema did not cluster with other symptoms2,22-24. It is possible that
patients put swelling in its own category as they considered the symptom more
manageable or less distressful. However, distress scores from ankle and leg swelling were
similar to those reported for shortness of breath and chest pain. This is contrary to how
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participants described these symptoms in interviews, in which fear, worry, and fears of
death often coincided with feeling shortness of breath or chest pain, but not swelling. One
participant stated, "The feet swelling isn't going to kill you, but when you can't catch the
air, that can take you out. And when you get the chest pain, that's stress to your heart. So
that again can take you out." Therefore, the perceived threat of a symptom may impact
the feelings of fear or worry for participants, which may explain the divergence in
results.
Reduced physical functioning was a common theme throughout interviews, as
participants stated that low physical functioning impacted their family life, household
chores, and ability to work. These interview findings were supported by high MLHFQ
scores, especially for making an earning difficult, in which the majority (53%) of
participants rated this item as a 5. Most participants discussed not being able to work due
to their symptoms or condition, and the four participants who did have jobs discussed the
challenge of managing their symptoms while working. Working to provide financial
income and a sense of accomplishment in a career both hold meaning, and the impact of
not having those should be explored in future interviews.
Participants also reported that experiencing HF symptoms made them feel like a
burden to others or that others would judge or pity them if they knew what they were
experiencing. These feelings tie into the symptom response of participants hiding or
downplaying their symptoms from others. Mothers especially downplayed their
symptoms while around their children and working women around their co-workers.
Women reported finding support mostly with their significant other or family members,
and some mentioned that they found support from God or their religion.
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Our study had several limitations. Firstly, participants self-reported their
diagnosis of HFpEF based on their ejection fraction being greater than or equal to 50% or
the participant reporting their doctor diagnosed them with HFpEF or diastolic heart
failure. HFpEF is a complex disease process and asking participants to self-report their
diagnosis is inferior to a confirmed diagnosis from a medical chart. Also, data from
qualitative interviews of 15 individuals were integrated with quantitative data of 44
individuals as a whole rather than examining quantitative data specific to each
interviewed participant. Future studies should aim to link these types of data for further
exploration of convergence, divergence, and expansion.

Conclusion
With a mixed-methods design, we were able to examine the symptom experience
of Black females with HFpEF. The majority of interview participants discussed that their
physical and emotional symptoms interacted with one another beyond simply cooccurrence, and positive correlations between symptom scales supported this theme.
Clinicians should include emotional/psychological symptoms and how they interact with
physical symptoms in their assessment. Women experienced shortness of breath with
fatigue, chest pain, and dizziness, while ankle and leg swelling often occurred alone.
Participants may place swelling in its own category as a common symptom that is
frequently present but not very distressful, as shown in survey data. Women reported that
shortness of breath and chest pain often caused them fear, worry, and fear of death.
Though symptom distress scores were not as high as expected for these symptoms, it may
be what these symptoms represent to participants that cause fear. Clinicians should pay
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close attention to how shortness of breath and chest pain impact their patients. The
participants reported their symptoms made them feel like a burden to others, or that
others judged or pitied them and often hid or downplayed their symptoms. The prominent
qualitative theme confirmed by quantitative data was that reduced physical functioning
impacted family life, household chores, and the ability to work.
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What’s New and Important?
•

Considering the increased burden of HF symptoms, greater risk, and worse
outcomes in females, Black Americans, and patients with HFpEF1,6-8, this study
seeks to illuminate the experiences of those who are underdiagnosed, undertreated
and have a greater symptom burden3,4.

•

Black women with HFpEF discussed interactions of physical and emotional
symptoms and positive correlations between symptom scales supported this
theme.

•

Participants reported feeling like a burden to others and hid or downplayed their
symptoms and reduced physical functioning impacted family life, household
chores, and the ability to work.
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Tables
Table 1: Merging of SMM components with QUAL and QUANT data collection
instruments

SMM Component

QUAL

QUANT

(interview guide)

(questionnaires)

What physical / emotional

MLHFQ

symptoms did you

SSQ-HF

Perception

Physical symptoms

experience in the past 4
weeks?
Emotional symptoms

What physical / emotional

MLHFQ

symptoms did you

PHQ-8

experience in the past 4
weeks?
How your symptoms make you
feel
Significance- what feeling
symptoms means to you

How did experiencing those
symptoms make you feel?
When you experience those
symptoms, what does that
mean to you?

Evaluation
Distress
Frequency

SSQ-HF
How often?
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SSQ-HF

PHQ-8
Severity
Impact on daily life

How severe?

SSQ-HF

How much do they impact

MLHFQ

your daily life?
Symptom causes

What do you think causes
your symptoms?

Response
Management and treatment

How do you think your
symptoms can be managed
or treated?

How you respond to

What do you usually do

experiencing symptoms, or what

when you are experiencing

you do when they become more

symptoms?

frequent, severe, impact your life

Have you ever

more?

hid/downplayed?

Person
Demographic

Tell me a little bit about

Screening

yourself…

questionnaire

Living situation

Demographics

Kids

questionnaire

Marital status

SILS

Job
Education
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Sociologic

Do you have a support
system to help?

Table 2: Study Sample Demographics
Frequency (Valid %) OR Mean (SD)
Quantitative sample

Qualitative sample

(n=44)

(n=15)

44 (100%)

15 (100%)

No High School Diploma

8 (18.2%)

5 (33.3%)

Diploma or GED

17 (38.6%)

5 (33.3%)

Associate degree

3 (6.8%)

1 (6.7%)

Bachelor’s Degree

7 (15.9)

4 (26.7%)

Master’s Degree

7 (15.9%)

0

Doctoral Degree

2 (4.5%)

0

Single

12 (27.3%)

3 (20%)

Married/ living with partner

20 (45.5%)

12 (80%)

Separated

3 (6.8%)

0

Divorced

4 (9.1%)

0

DEMOGRAPHICS

Race/ethnicity
Black
Education

Current marital status
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Widowed

5 (11.4%)

0

Age (years)

51.75 (11.1)

46.9

# of children

2

3

# people in household

3

4

Length of HF Diagnosis
0 – 12 months

11 (25%)

>1 year – 2 years

15 (34.1%)

3 years – 4 years

13 (29.5%)

5 years – 8 years

5 (11.4%)

Primary Insurance Status
None

0 (0%)

Medicare / Medicaid

24 (54.6%)

Public (marketplace)

7 (15.9%)

Private (employer)

10 (22.7%)

Other

3 (6.8%)

BMI Categories
Underweight (< 18.5)

2 (4.5%)

Healthy (18.5 – 24.9)

25 (56.8%)

Overweight (25 – 29.9)

6 (13.6%)

Obese (> 30)

11 (25%)

Single item literacy screener
Never

26 (59.1%)

Rarely

8 (18.2%)
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Sometimes

5 (11.4%)

Often

5 (11.4%)

Always

0 (0%)

Table 3: Integration of QUAL and QUANT data organized within the SMM
framework
Themes

QUAL - Participant contextualization

QUANT Variables
Mean (SD) | Median

Perception

Emotional

“Um, I would say the worst my symptoms are, MLHFQ - making

symptoms co-

the more, the more that I worry.”

occurring with

you worry? (N=43)
4.07 (1.3) | 5

physical

“If I’m in a lot of pain a lot of times or I have

symptoms

shortness of breath and then it can cause

MLHFQ by- making

anxiety and worry, you know, it all kind of

you feel depressed?

goes together.”

(N=32)
2.34 (2.1) | 1

“And the moment I become depressed and start
thinking about my condition too much, I find

PHQ-8 - down,

that I start experiencing (physical) symptoms.”

depressed, or
hopeless? (N=27)
1.16 (1.2) | 1
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Shortness of

“The shortness of breath and fatigue and

Shortness of breath

breath, fatigue,

tiredness, that all happens at once.”

AND fatigue- 97%

dizziness, and

(38/39)

chest pain

“I would definitely say the fatigue and

occurring

shortness of breath. I would say they happen

Chest pain AND

together and leg

together.”

dizziness- 68%

or ankle

(15/22)

swelling

“The breathing and the (chest) pain will

occurring alone

happen together.”

Shortness of breath,
fatigue, dizziness,

“Pain in the chest may come with fatigue and

AND chest pain -

also loss of appetite, but the swollen legs

30% (13/44)

maybe comes alone”
SSQ-HF Leg or ankle
“I can also have swollen feet by itself, because

swelling (N=39)

swollen feet, I would definitely say, that that’s

-How often?

around 24/7.”

2.69 (.61) | 3
-How severe?
2.03 (.87) | 2
-How distressful?
1.95 (1.3) | 1

Shortness of

“At times with the dizziness, with shortness of

SSQ-HF Chest pain

breath and chest

breath, fear can kick in because you never

(n=22)
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pain causing

know when the day is going to be your day.

-How often?

fear, worry, and

And by that, I mean, that you say goodbye to

2.50 (.67) | 2.5

fears of death

this Earth or that you may check in to the

-How severe?

hospital.”

1.95 (.49) | 2
How distressful?

“Well, when my heart hurts it’s that (that

1.91 (1.1) | 1.5

scares me). People get scared of dying when
that happens. Or you can’t breathe good, you

SSQ-HF Shortness of

get scared of stuff like that. I mean, I want to

breath (N=39)

live to see my grandkids, you know what I’m

-How often?

saying?”

2.87 (.89) | 3
-How severe?

“You get a little scared when you can’t catch a

2.36 (.81) | 2

breath or when you do get the chest pain, it

How distressful?

puts little scares in you.”

2.44 (1.2) | 3

Feeling like a

“I would definitely say that that feels scary to

MLHFQ by- making

burden to others

have to lean on somebody. I would also say if I you feel you are a
don't, I don't, I don't want to be a burden on

burden to your family

anybody.”

or friends? (N=37)
2.93 (1.8) | 3.5

“Sometimes that it also makes... it can make
me feel like a burden because you're supposed
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to take care of your children not your children
take care of you.”
Evaluation
Daily life

“Even with my walker, I'm not going to get

MLHFQ by- making

affected by

there. I mean, I can tell myself. And then, to

your working around

physical

myself, I'm saying, I'm going to go. And I

the house or yard

functioning

wouldn't get to the driveway. So, I've got to go

difficult? (N=44)

back to the house.”

3.20 (1.5) | 3.5

“What normally would take me an hour to

MLHFQ by- making

clean, takes me well into four or five hours

your going places

because I had to stop because I just get so out

away from home

of breath.”

difficult? (N=43)
3.25 (1.5) | 3.5

“It makes me feel uncapable of doing just
regular, normal things.”
Feelings of

“That I'm not experiencing the world at its

MLHFQ by- making

missing out

fullest, you know? And when I do go out and I

you eat less of the

get out there, I'm like a kid in a candy store. I

foods you like?

want to see everything, but I just can't.”

(N=38)
2.55 (1.5) | 3

“Um, I feel left out because everybody else,
you know, I can't expect them to stop their
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lives and not go just because I can't, I feel left

MLHFQ by- making

out, but at the same time we do watch movies

your relating to or

here at the house.”

doing things with
your friends or family

“I guess you can also say sometimes I feel

difficult? (N=44)

deprived as well, deprived in the sense that I

3.18 (1.4) | 3

can't have all those seasonings and butters
anymore. So, I feel really deprived about that.”
Response
Reducing

“If, if your, if your body's not feeling right,

MLHFQ by- making

activity level as

you know, or you're overexerting yourself,

you sit or lie down to

a response to

check in, and say hey, you got to slow down.”

rest during the day?

symptoms

(N=43)
“So, first you rest and see if it will go away on

3.50 (1.5) | 4

its own, and then you decide what to do.”

“I personally try to keep my activities low.”
Not sharing

“Yeah, when I sit down, and my chest is

feelings or

hurting. I sit down, and that's when I'm

downplaying

masking it. They say, well, ‘Mom, why are

symptoms

you sitting down?’ I say, ‘I'm taking a break.’”
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n/a

“You have to act normal. So, you have to
pretend that you're okay. I think it's really
tiring, really exhausting.”
Person
Inability to

“Yeah, it does affect me because I'm a

MLHFQ by- making

work or

hairdresser. My work includes a lot of moving,

your working to earn

difficulty

standing. So, when I have swollen feet I cannot a living difficult?

working due to

go to work.”

(N=37)

symptoms

3.48 (2.0) | 5
“And I've worked most of my life, but I haven't
worked in the last three years because of my
heart.”

Support

“I feel at ease talking about what I feel with
my husband and pastor, I really do. […] There
ain't nothing I can't go to my husband and talk
about.”

“But I pray. I'm religious. I pray to God. I
know He is going to get me through anything.
Any trial I go through, I believe He will help
me. Even though I'm scared, God don't want
me to be scared.”
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n/a

*N=any score other than 0, MLHFQ Did your HF prevent you from living as you wanted
during the past month (4 weeks) by (0-5) PHQ-8 Over the last 2 weeks, how often have
you been bothered by any of the following problems (0-3),

Table 4: Questionnaire Total Scores
Questionnaire

Mean (SD)

Median (Minimum-Maximum)

MLHFQ

64.14 (9.42)

63.0 (21 to 95)

SSQ-HF

39.20 (16.03)

41.5 (0 to 68)

8.98 (6.24)

7.5 (0 to 24)

PHQ-8

*MLHFQ=Minnesota Living with Heart Failure Questionnaire, SSQ-HF=Symptom
Status Questionnaire – Heart Failure, PHQ-8=Personal Health Questionnaire-8
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Summary
Overview of Manuscripts' Contributions
The dissertation compendium consists of 3 manuscripts: (1) an integrative review of
heart failure (HF) symptom cluster literature to identify themes within the Symptom
Management Model (SMM) and highlight gaps that researchers should pursue in the
future; (2) a feasibility study of a convergent mixed methods parallel study protocol for
studying the HF symptom experience and how symptoms cluster in Black women with
Heart Failure preserved Ejection Fraction (HFpEF); and (3) a qualitative descriptive
analysis of individual interviews with Black women with HFpEF about their background
and symptom experience, and integration of qualitative themes with quantitative
symptom data (1). Together, these manuscripts illuminate the symptom experience of
Black women with HFpEF, a population that has been understudied in current HF
symptom cluster research (2-19). These manuscripts serve as the first step to inform the
design and future implementation of a large-scale mixed methods HF symptom cluster
study to form statistically meaningful symptom clusters and integrate qualitative findings
to gain new perspectives on this population's symptom experience.
The comprehensive integrative review of HF symptom cluster literature
synthesized themes from 18 manuscripts that were eligible for analysis (19). Themes
were organized within the SMM (1). The integrative review showed that HF symptom
clusters exist and can be used in clinical practice for symptom monitoring and risk
assessment. However, current literature minimally examined sex differences in HF
symptom clusters and lacked racial diversity, as the majority of participants in American
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studies were White (2-19). Additionally, none of the included manuscripts utilized
qualitative methods to allow participants to describe their symptom experiences.
The second manuscript reported the results of the feasibility study and preliminary
symptom cluster analysis. This study was conducted to determine an innovative symptom
cluster study design's feasibility and acceptability in an underrepresented population. This
study's results support the study protocol's feasibility and acceptability, as all benchmarks
were met. We conducted a hierarchical cluster analysis with the feasibility study sample
(N=44) to test processes and form preliminary clusters. Three clusters of individuals were
identified, consisting of a highly symptomatic cluster, mildly symptomatic cluster, and a
psychologically symptomatic cluster. We compared the preliminary clusters on
demographics and questionnaire responses. However, hypothesis testing was not the
focus of this study due to the feasibility design and small sample. Further exploration
should be conducted in the future with a large sample of participants.
The final manuscript consisted of qualitative and mixed methods integration
results. Qualitative themes about the symptom experience of Black women with HFpEF
emerged about physical and emotional symptoms co-occurring and interacting, chest pain
and shortness of breath causing fear and anxiety, women feeling like a burden to their
families, and physical limitations impacting daily life, activities with friends and family,
and the ability to work. Quantitative symptom data were integrated with these themes to
show how results converged or diverged. Symptom scale results coincided with interview
findings. For instance, participants reported high impact scores for feeling like a burden
to others, an inability to work, and missing out on activities with friends and families due
to their condition, all of which were prominent qualitative themes. Some results diverged.
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For instance, interview participants said shortness of breath and chest pain made them
feel fear, anxiety, and fear of death, yet survey respondents rated shortness of breath and
chest pain symptom distress similar to that of ankle and leg swelling. Ankle and leg
swelling often occurred alone and was not noted to be particularly distressful in
interviews and was never tied to fears of death. This discordance in results may be due to
what the symptom represents. Some participants described their breathing and chest pain
as things that could "take you out" or thought of them as dealing directly with the heart.
In comparison, they felt the swelling often occurred, and even though it may be
bothersome and distressful, they did not feel they would die from it.

Limitations
There were several notable limitations of this dissertation study. First, the integrative
review only searched three databases, and all manuscripts that underwent full-text review
were from one database. Utilizing more databases and alternative search terms could
result in a larger sample of manuscripts. Second, study participants self-reported a
diagnosis of HFpEF. We asked participants if their doctor had given them a diagnosis of
HFpEF or diastolic HF (with an ejection fraction greater than or equal to 50%). They
either responded yes, no or unsure. If participants were unsure, they were encouraged to
call the PI to discuss their diagnosis. One participant did call to discuss her eligibility and
was deemed eligible for the study. This option was helpful for those who were unsure,
but a confirmed diagnosis from a medical chart would be preferable. Third, we did not
know which quantitative data belonged to each interview participant due to an attempt to
separate patient identifiers from health data for confidentiality purposes. This meant that
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mixed methods integration occurred with quantitative data as a whole rather than
individual responses. Connecting individual symptom scores to qualitative interview data
could have provided us with additional insights.

Importance of Theory, Model, or Framework
The SMM was central to this dissertation. The SMM was used as a framework for
an integrative review of HF symptom cluster literature due to its multifaceted nature that
encompasses various components that influence the symptom experience as a whole (1).
The model was then used to design and plan multiple aspects of the dissertation study,
including guiding the research question, informing proposal development, and
influencing symptom questionnaire selection. The SMM was also used as a framework
for the semi-structured interview guide, qualitative content analysis, triangulation, and
merging of qualitative and quantitative results. Utilizing the SMM as a framework from
start to finish allowed for the cohesion of findings and concepts across all dissertation
studies, ultimately adding strength and rigor to findings.
The dissertation study also further describes how aspects of person and symptom
experience, which are components of the SMM, interact to illuminate the symptom
experience as a whole. Future research could incorporate more components of the model
to further explore interactions. The SMM combined with domains of the MLHFQ
provided added information on physical symptoms and emotional symptoms, a
distinction that was not present in the model.

Overall Findings
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This dissertation's results support the feasibility and acceptability of a mixed
methods study protocol for studying symptom clusters in Black women with HFpEF.
Recruiting a larger sample to form meaningful clusters should be pursued in future
research to describe this population's symptom experience further. The studies also
highlight the importance of emotional/psychological symptoms in HF. Current HF
treatment guidelines acknowledge emotional/psychological symptoms in HF, but
guidelines do not exist to treat or manage these symptoms (20). Other HF symptom
cluster studies have shown that emotional and psychological symptoms happen together
when they cluster together or happen simultaneously (2-19). However, without the
qualitative interviews, we could not explain how these symptoms interact with one
another. Many interview participants discussed how they believed their physical
symptoms caused their emotional symptoms or vice versa. This finding highlights the
value of qualitative methods in symptom cluster research.
Interviews also showed how a woman's background or lifestyle impacts their
symptom experience. Minnesota Living with Heart Failure Questionnaire (MLHFQ)
scores were high for feeling like a burden to others, and these results were confirmed in
qualitative interviews where almost all participants discussed feeling like a burden when
they were unable to carry out their normal tasks or needed assistance at work or home
(21). The distress women felt when not being able to care for their children, partner, or
family members or work, like they used to before diagnosis, was evident and may explain
why women have higher rates of depression (23, 24). Exploring whether men also feel
like a burden to others and how they characterize their emotional/psychological
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symptoms would help find differences and similarities in each sex/gender's symptom
experience.

Research Trajectory
This dissertation provides the background knowledge and proof of concept data
necessary for conducting a large-scale mixed methods HF symptom cluster study with a
population of Black women with HFpEF. Study materials have been developed and
tested. Feasibility benchmarks were all met, and participants gave the study high ratings
for acceptability. Facebook ad campaigns have also been developed and could be reused
for a larger study. To recruit a large enough sample to form statistically significant
symptom clusters, additional funding is needed to compensate study participants, run
Facebook ad campaigns, and support study staff.
When conducting a larger scale study, it would be ideal to pair quantitative and
qualitative data together for each participant rather than only merging quantitative data as
a whole with qualitative data. This dissertation aimed to answer the research question of
what is the symptom experience and how do symptoms clusters for Black women with
HFpEF? Future research could also compare the symptom experience and symptom
clusters of Black females with HFpEF to persons of different race/ethnicities, males, and
to patients with another type of HF with a reduced ejection fraction. We could also
explore how age affects symptom perception and clustering, since younger age has been
noted to correspond with more symptom distress and the most symptomatic cluster also
had the youngest average age.
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Contribution to Health, Nursing and Clinical Care
This dissertation study provides key insights into nursing, research, and clinical
care. First, this dissertation illuminates the symptom experience of Black women with
HFpEF. While conducting qualitative interviews, many participants discussed their
enthusiasm for being included in the research study, helping others by sharing their
stories, and wanting their voices to be heard. This enthusiasm for participation shows that
underrepresented populations in research may not actually be hard to reach or unwilling
to participate, but that recruitment tactics have to be more targeted to achieve diversity
and inclusion. When first using Facebook for recruitment, almost all screening
questionnaires were completed by White respondents. It took targeted efforts to reach our
population of interest, in which we developed Facebook ads geared specifically to our
population of interest. When we were only using post within Facebook groups, almost all
respondents were White. This feasibility study serves as a steppingstone to recruiting a
large population for a full-scale study and provides key information for recruiting Black
women in future HF studies.
This dissertation study also highlights the clinical implications of
emotional/psychological symptoms. This was a theme in the integrative review, as HF
symptom cluster studies found emotional/psychological symptoms tied to worse
outcomes and increased cardiac risks. This theme continued in the mixed methods study,
as participants discussed interactions between their physical and psychological
symptoms, and symptom scales had moderately to strongly correlated. It is imperative
that emotional/psychological are recognized, treated, and included in HF treatment
guidelines.
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Appendix A: IRB Approval

Institutional Review Board for Human Research (IRB)
Office of Research
Integrity (ORI)
Medical University of
South Carolina
Palmetto
Place Office Park 1
South Park Circle,
Bldg. 1, Suite 401
Charl
eston, SC. 29407
Federal Wide
Assurance #
1888
APPROVAL:

This is to certify that the research proposal Pro00101261 entitled:
A Mixed Methods Approach to Symptom Clusters in Black Women with Heart Failure
Preserved Ejection Fraction: A Feasibility Study
and submitted by: Alexandra Ruppe
Department: Medical University of South Carolina
Sponsor: null, MUSC CON Diversity and Inclusion Dissertation Award

Sponsor Protocol Version: 1
Dated: 7/31/2020

For consideration has been reviewed by IRB-I - Medical University of South
Carolina and approved with respect to the study of human subjects as adequately
protecting the rights and welfare of the individuals involved, employing adequately
methods of securing informed consent from these individuals and not involving undue
risk in the light of potential benefits to be derived therefrom. Additionally, the
Institutional Review Board for Human Research (IRB) recommends approval of the
investigator's request for Waiver of Consent pursuant to 45 CFR 46.116(d) because
the research involves no more than minimal risk to the subject, the waiver will not
adversely affect the rights and welfare of the subjects, and the research could not be
practicably carried out without the waiver. No IRB member who has a conflicting
interest was involved in the review or approval of this study, except to provide
information as requested by the IRB.
Original Approval Date: 8/7/2020
Required Status Update Report: 8/6/2021
Type: Expedited
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Chairman, IRB-I - Medical
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involving human subjects is contingent upon my agreement:
1. To report to the Institutional Review Board for Human Research (IRB) any adverse events or
research related injuries which might occur in relation to the human research. I have read and
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2. To submit in writing for prior IRB approval any alterations to the plan of human research.
3. To submit timely status update reports of this research as requested by the IRB.
4. To maintain copies of all pertinent information related to the research activities in this project,
including copies of informed consent agreements obtained from all participants.
5. To notify the IRB immediately upon the termination of this project, and/or the departure of
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investigator from this Institution and the project.
* Electronic Signature: This document has been electronically signed by the IRB
Chairman through the HSSC eIRB Submission System authorizing IRB approval for
this study as described in this letter.

Initial Review Approval of Full Board or Expedited Research

8/10/2020

143

Appendix B: Recruitment Materials
Facebook ad / posts with possible images / text combos
Are you a Black woman with heart failure? Are you 35-74 years old? We want to hear
about your experience with symptoms.

Answer questionnaires about your symptoms and how heart failure symptoms affect your
life in 20-30 minutes. Additionally, you may participate in an optional interview about
your health and symptoms if you are interested.

Receive a $25 Amazon eGift Card as a thank you for your participation.

We need to hear your voice and experiences to help drive heart failure research within the
Black female community.

Participants will receive an Amazon eGift Card ($25) by email or text after completing
questionnaire and another Amazon eGift Card ($25) if they complete an interview.

Click here to answer screening questions and see if you qualify for the study.

IRB Number: « PRO00101261»
Date Approved «08/07/2020»
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Photos:
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IRB Number: « PRO00101261»
Date Approved «08/07/2020»

Electronic flyer:
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Appendix C: Permissions
Permission for Minnesota Living with Heart Failure Questionnaire
MLHFQ - Instructional or Student Use License

The Minnesota Living With Heart Failure® Questionnaire - Educational Use License is the correct
license type to choose when the LICENSEE is a student or teacher at an academic institution
and will use the Questionnaire exclusively for student project(s) or teaching purposes.

Please read the terms and conditions of this license agreement ("Agreement")
carefully.
By clicking "SUBMIT" on the "Accept/acknowledge terms" page during the
Checkout process,
you are agreeing to the following terms and conditions on behalf of the Licensee
identified below, and you represent and warrant that you are authorized to do so.
Minnesota Living with Heart Failure Questionnaire Educational License
License Fee:
License Fee is $0 USD, payable upon checkout.
Licensee: Alexandra Ruppe
Company - Medical University of South Carolina
Contact Email - moseleal@musc.edu
Contact Phone - 8034176635
TERMS AND CONDITIONS - The following terms and conditions govern this
Agreement by and between the Regents of the University of Minnesota, a
constitutional corporation under the laws of the State of Minnesota, ("University") and
the Licensee.
Definitions - For purposes of this agreement, the following terms have the following
meanings.
"Accompanying Documentation" means the following:
MLHFQ FDA MDDT Qualification Package (288 KB PDF)
"Approved Copies" means duplicates of the Work that shall include the statement
below:
©1986 Regents of the University of Minnesota, All rights reserved. Do not copy or
reproduce without permission. LIVING WITH HEART FAILURE® is a registered
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trademark of the Regents of the University of Minnesota.
"Effective Date" means the date when the Licensee clicks the button indicating
agreement with all the terms and conditions of the license and has successfully
completed payment in the checkout process. The Effective Date is Mar 26, 2020.
"Licensed Mark" means US Trademark Registration No. 2,378,845 for the mark
"LIVING WITH HEART FAILURE", registered to the Regents of the University of
Minnesota.
"Purpose" Means the use of the Licensed Technology pursuant to the Terms &
Conditions of this Agreement, for use by the Licensee, who must be a student or
teacher at an academic institution, exclusively for student project(s) or didactic
purposes and for no other purpose.
"Licensed Technology" means collectively the Work, the Licensed Mark,
Approved Copies and the Accompanying Documentation.
"Term" The Term of this Agreement shall commence on the Effective Date and
shall expire, without any further action by the University, on the tenth (10th)
anniversary of the Effective Date.
"Work" means the Living with Heart Failure ® Questionnaire and the Instructions
for Data Collection and Scoring. This Work is in the English language; and is
identified as University Case #: 94019.
Grant of License - Subject to the terms and conditions of the Agreement,
University hereby grants to Licensee and Licensee accepts a limited, non-exclusive,
non-transferrable, non-sub-licensable, revocable, world-wide license to reproduce
the Work and use Approved Copies for the Purpose set forth in this Agreement.
Rights of the U.S. Government and Third Parties - No provision of this Agreement
limits, conditions or otherwise affects the United States of America's or any other third
party's rights and interests in the Licensed Technology.
University Intellectual Property Rights -Title to and ownership of the Licensed
Technology shall at all times remain with the University and Licensee shall not
have any title or ownership interest therein. All rights not expressly granted to
Licensee under the Agreement are reserved by University.
Use of the University's Names and Trademarks - No provision of the Agreement
grants the Licensee any right or license to use the name, logo, or any marks owned by
or associated with the University or the names, or identities of any member of the
faculty, staff, or student body of the University except as may be otherwise provided
in this Agreement and Licensee shall not use such names or marks without the prior
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written approval of the University's Office of University Relations.
Payment Terms - Licensee shall pay, upon checkout, the License Fee and any
applicable taxes, duties, fees, excises or other charges. All amounts payable hereunder
by Licensee are non-refundable and non-creditable. All amounts payable hereunder by
Licensee shall be payable in United States funds.
Protection of Proprietary Rights - Licensee shall take all steps reasonable to
protect UNIVERSITY's ownership rights in the Licensed Technology.
LICENSEE shall not:
• make copies of the Licensed Technology except as may be allowed for the
Purpose of the Agreement; remove the UNIVERSITY copyright notice and/or
other proprietary notices;
• alter or otherwise modify the Licensed Technology;
• create derivative works based in whole or in part on the Licensed Technology;
• reproduce, resell or otherwise distribute Licensed Technology.
Audit - Licensor may audit Licensee's usage and records directly relating to the
Licensed Technology to ensure that Licensee is using the Licensed Technology in
compliance with the Agreement. Such audit shall be upon fifteen (15) working days
advance written notice of such audit, which shall be conducted during normal
business hours.
Termination - If the Licensee breaches or fails to perform one or more of its
obligations under the Agreement, the University may deliver a written notice of default
to the Licensee. Without further action by a party, the Agreement shall terminate if the
default has not been cured in full within thirty (30) days. The University may terminate
the Agreement immediately by delivering to the Licensee a written notice of
termination if the Licensee or its agents or representatives commences or maintains an
action in any court of competent jurisdiction or a proceeding before any governmental
agency asserting or alleging, in any respect, the validity or enforceability of any of the
Licensed Technology.
The Licensee shall notify the University, in writing, at least thirty (30) days prior to the
commencement of any such action or the instigation of any such proceeding. Upon
termination or expiration, all rights granted to Licensee under this Agreement, with
respect to the Licensed Technology, terminate; and upon request Licensee shall return
(or destroy and certify destruction) of any copies of the Licensed Technology, however
Licensee shall be permitted to keep copies of the Licensed Technology to ensure
compliance with this Agreement and for its own internal data management purposes.
Indemnification - The Licensee shall release, defend (upon the request of the
University), indemnify, and hold harmless the University and its regents, employees,
agents and representatives from any loss, claim, damage, or liability, of whatever
kind or nature (including, but not limited to, reasonable attorneys’ and investigative
expenses), that arises from or in any way relates to (i) the use of the Licensed
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Technology (including but not limited to any product that contains or is
manufactured with the use of the Licensed Technology) or (ii) Licensee’s breach of
any obligation or representation under the Agreement.
Permitted Trademark Usage - Licensee's use of a Licensed Mark in any manner
shall inure to the benefit of the University. The Licensee agrees that it will not: (i)
challenge, cause, or assist any other person to contest the validity of a Licensed Mark
or the University's sole and exclusive rights in each Licensed Mark;
(ii) use a Licensed Mark or any components thereof, or any words or designs
confusingly similar thereto, in any way other than in connection with the Licensed
Technology; (iii) attempt to register or register, assist in registering, or cause to be
registered a Licensed Mark or any components thereof or any words or designs
confusingly similar thereto, as or within any trademark, corporate name, trade name, or
domain name; or (iv) commit any act that might prejudice or adversely affect the
validity of a Licensed Mark or the University's rights in each Licensed Mark. The
Licensee shall use the Licensed Marks in full compliance with all applicable federal,
state, territorial, and provincial laws, including all applicable federal export laws and
regulations.
Trademark Standards - Licensee recognizes the importance to the University of
maintaining high, uniformly applied standards of quality in the Licensed Technology
identified by a Licensed Mark, and covenants that Licensed Technology covered by
this Agreement shall be of high standard and quality. The Licensee agrees to follow
any and all written specifications of the University relating to the nature and quality of
Licensed Technology and the use of the Licensed Marks. From time to time during the
term of the Agreement, as requested by the University in writing, the Licensee shall
submit sample(s) of requested
Licensed Technology to the University for its inspection and approval. Such
specimen(s) or sample(s) may be used by University in the filing, prosecution or
maintenance of a Licensed Mark. Licensee further agrees to cooperate, from time to
time as necessary, with the University in the filing, prosecution and maintenance of
the Licensed Marks.
Translations - Licensee may translate the questionnaire solely for its own internal,
non-commercial use. University is not responsible for and assumes no liability for
the accuracy of the translation.
Disclaimer - THE LICENSED TECHNOLOGY IS PROVIDED "AS IS."
UNIVERSITY MAKES NO WARRANTIES OR REPRESENTATIONS
RELATING TO THE LICENSED TECHNOLOGY, EXPRESS OR IMPLIED,
STATUTORY OR OTHERWISE, AND EXPRESSLY EXCLUDES THE
WARRANTY OF NON-INFRINGEMENT OF THIRD-PARTY RIGHTS,
FITNESS FOR A PARTICULAR PURPOSE OR MERCHANTABILITY.
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UNIVERSITY DOES NOT WARRANT THAT THE LICENSED TECHNOLOGY
WILL SATISFY LICENSEE'S REQUIREMENTS.
LIMITATION OF LIABILITY - UNIVERSITY IS NOT LIABLE FOR ANY
INDIRECT, INCIDENTAL, SPECIAL, OR CONSEQUENTIAL DAMAGES, OR
DAMAGES FOR LOSS OF PROFITS INCURRED BY THE LICENSEE OR ANY
THIRD PARTY, WHETHER IN AN ACTION IN CONTRACT OR TORT
(INCLUDING NEGLIGENCE), OR ANY OTHER LEGAL THEORY, EVEN IF THE
UNIVERSITY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH
DAMAGES. IN NO EVENT WILL THE UNIVERSITY'S AGGREGATE
LIABILITY UNDER THIS AGREEMENT EXCEED THE LICENSE FEE PAID TO
THE UNIVERSITY UNDER THE AGREEMENT. THIS LIMITATION APPLIES
REGARDLESS OF WHETHER OTHER PROVISIONS OF THIS LICENSE HAVE
BEEN BREACHED OR HAVE PROVEN INEFFECTIVE. THE EXISTENCE OF
MORE THAN ONE CLAIM WILL NOT ENLARGE OR EXTEND THESE LIMITS.
LICENSEE ACKNOWLEDGES AND AGREES THAT THE FOREGOING
LIABILITY LIMITATIONS ARE ESSENTIAL ELEMENTS OF THIS LICENSE
AND THAT IN THE ABSENCE OF SUCH LIMITATIONS, THE MATERIAL AND
ECONOMIC TERMS OF THIS LICENSE WOULD BE SUBSTANTIALLY
DIFFERENT.
Export and Regulatory Restrictions - Copyright - The Licensee shall comply with
all then-current applicable export laws and any regulations (e.g. federal, state, local,
or provincial) regarding the use of the Licensed Technology in the relevant territory.
Right to Injunctive Relief - Licensee acknowledges and agrees that monetary
damages are not sufficient to compensate University in the event of Licensee's material
breach or violation of this Agreement, and that University may be irreparably harmed
by such breach or violation, and that University will have the right to seek other
remedies available to it in law and equity to remedy such breach or violation, including
injunctive and equitable relief. If Licensee fails to perform an obligation or otherwise
breaches one or more of the terms of this Agreement, Licensee shall pay the
University's costs and expenses (including actual attorneys' and investigative fees) to
enforce the terms of this Agreement.
Governing Law and Forum - The internal laws of the state of Minnesota shall
govern the validity, construction and enforceability of this Agreement, without
giving effect to the conflict of laws principles thereof. Any suit, claim, or other
action to enforce the terms of this agreement, or any suit, claim or action arising out
of or related to this agreement, may be brought only in the state courts of Hennepin
County, Minnesota. The Licensee hereby submits to the jurisdiction of that court
and waives any objections it may
have to that court asserting jurisdiction over the Licensee or its assets and property.
This Agreement is not to be governed by the United Nations Convention on Contracts
for the International Sale of Goods, or by the Uniform Computer Information
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Transactions Act (UCITA) as may be enacted by the State of Minnesota.
Entire Agreement - This Agreement constitutes the entire understanding of the
parties with respect to the subject matter hereof, and supersedes all prior agreements
and understandings of the parties on such subject matter. This Agreement may be
amended, only in writing, and duly executed by all the parties.
Assignments - The Licensee may not assign or delegate any right or duty under this
Agreement, unless the University has consented, in writing, to such assignment or
delegation. An assignment or delegation made in violation of this section shall be void
and shall not bind the other party.
Compliance With Laws - Licensee represents and warrants that its use of the
Licensed Technology will comply with all applicable laws and regulations.
Survival - The following provisions (to the extent they appear in this Agreement)
survive termination of the Agreement: "Definitions, University Intellectual Property
Rights, Protection of Proprietary Rights, Payment Terms, Termination, Disclaimer,
Limitation of Liability, Indemnification, Export Control, Right to Injunctive Relief and
Attorney's Fees, Governing Law, and any other provision, which by its nature is
intended to survive.
Relationship of the Parties - In entering into, and performing their duties under the
Agreement, the parties are acting as independent contractors and independent
employers. No provision of the Agreement creates or is to be construed as creating a
partnership, joint venture, or agency relationship between the parties. No party has the
authority to act for or bind the other party in any respect.
Severability - If a court of competent jurisdiction adjudges a provision of the
Agreement to be unenforceable, invalid, or void, such determination is not to be
construed as impairing the enforceability of any of the remaining provisions hereof
and such provisions will remain in full force and effect.
Notice - In order to be effective, all notices, requests, and other communications that a
party is required or elects to deliver must be in writing and must be delivered
personally, or by facsimile or electronic mail (provided such delivery is confirmed), or
by a recognized overnight courier service or by United States mail, first-class, certified
or registered, postage prepaid, return receipt requested, to the other party at its address
set forth below or to such other address as such party may designate by notice given
under this section:
If to University:
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Office for Technology Commercialization,
University of Minnesota Attn: Contracts
Manager
McNama
ra
Alumni
Center
200 Oak
St. SE,
Suite 226
Minneapolis, MN 55455
OTCAgree@umn.edu
If notice alleges breach of the Agreement, a copy must be sent to:
Office of the General Counsel,
University of Minnesota Attention:
Director of Transactional Law
Services.
200 Oak Street, SE Minneapolis, MN, 55455
Contracts@mail.ogc.umn.edu
If to Licensee: As set forth above in the "Licensee" section.
Accept Terms - Clicking "SUBMIT" on the "Accept/acknowledge terms" page during
the Checkout process indicates that you agree with the terms and conditions of this
license agreement, and agree to receive required notices from the University of
Minnesota electronica
Permission for Symptom Status Questionnaire - Heart Failure
From: Seongkum Heo
Sent: Friday, June 19, 2020 3:35 PM
To: Ruppe, Alexandra [moseleal@musc.edu]
Subject: Re: SSQ-HF use for dissertation

Hi Alexandra,
Ok. Great. I attached the instrument.
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I hope that everything goes very well for you and your project.
Seongkum Heo, PhD, RN, AHAF, FHFSA
From: Ruppe, Alexandra [moseleal@musc.edu]
Sent: Friday, June 19, 2020 2:07 PM
To: Seongkum Heo [heo_s@mercer.edu]
Subject: Re: SSQ-HF use for dissertation

Exactly! That would be great, Dr. Heo. Thanks so much. I will keep you posted on
progress and I can send you manuscripts for approval before submitting any for
publication.

From: Seongkum Heo [heo_s@mercer.edu]
Sent: Friday, June 19, 2020 1:32:05 PM
To: Ruppe, Alexandra [moseleal@musc.edu]
Subject: Re: SSQ-HF use for dissertation
Hi Alexandra,
Thank you for your interest.
Yes, I think that it will be good to test in African Americans.
In addition, the items in the MLHFQ does not assess symptoms, but the limitations (or
effects) on daily activities, which are different from symptom themselves.
If you want to use SSQ-HF, I will send you the instrument.
Best wishes, Seongkum Heo, PhD, RN, AHAF, FHFSA
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Appendix D: Instruments Utilized in Dissertation Study
Section 1: REDCap Survey – Instructions and Screening Questionnaire

Welcome and Instructions:
Thank you for your interest in our study. We are excited to have you!
The purpose of this study is to explore symptoms for Black women with heart
failure. Black women have not been included in the majority of heart failure research. It
is important that Black women have a voice and the ability to share their symptom
experience. The goal of this research is to study clusters of heart failure symptoms in
Black women to eventually improve symptom education, monitoring, and treatments.
First, we ask that you complete a short screening questionnaire to see if you are
eligible to participate in the study. The screening will take less than 5 minutes. If you are
eligible and you would still like to participate, you will be asked to answer questions
about your health status, background, and heart failure symptoms. The survey will take
about 20-30 minutes to complete. This research study is completely voluntary. Even after
you have started the survey, you have the right to refuse to answer any question or stop at
any time. Completion of this survey means you consent to participate in the research
study. This research study comes with a small risk of loss of confidentiality (meaning
someone finding out about your health condition or responses). We have minimized this
risk as much as possible by not tying your name or information to any of your responses
and keeping all study data on password-protected, encrypted, and secure platforms.
You will receive a $25 Amazon e-gift card as a token of appreciation for your
participation in the study. After completing the survey, please fill out the contact
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information survey so we know where to send your gift card. You

will be asked if you

are interested in being contacted for an interview about your symptom experience. These
interviews will only be between you and me over the phone or video conference and will
take approximately 30

minutes to 1 hour. Interviews will be audio-recorded and

transcribed to written word. Audio recordings will be deleted as soon as transcription is
complete to protect your identity. If you are asked to participate in an interview, you will
receive an additional $25 Amazon e-gift card after it is completed.
Thank you for allowing me the opportunity to share my research study with you.
If you have any questions/comments or you would like to answer survey questions over
the phone, please call, text, or email me. I would love to hear from you!

Sincerely,
Alex Ruppe, BSN, BSPH, RN Cardiac Nurse
Ph.D. Candidate, Medical University of South Carolina College of Nursing
(803) 417-6635
moseleal@musc.edu

--- PLEASE ANSWER THE FOLLOWING QUESTIONS TO SEE IF YOU ARE
ELIGIBLE TO JOIN THE STUDY --PLEASE ONLY ANSWER THIS QUESTIONNAIRE ONE TIME PER PERSON

1. Have you ever received a diagnosis of heart failure?
Yes
No
Unsure
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2. Did your doctor tell you the type of heart failure you have is called diastolic
heart failure (also known as heart failure with preserved ejection fraction)?
Yes, my ejection fraction is 50% or greater
No, I have a reduced ejection fraction (<50%)
Unsure
(If you are unsure about whether you have diastolic heart failure or
heart failure preserved ejection fraction, please contact the primary
investigator to determine if you are eligible to participate in this study.
Alex Ruppe, BSN, BSPH, RN (803) 417-6635
moseleal@musc.edu)
3. Are you at least 35 years old?
Yes
No
4. Are you younger than 75 years?
Yes
No
5. Are you female?
Yes
No
6. Do you identify as a woman?
Yes
No
7. Is the race you primarily identify with Black or African American?
Yes
No

157

8. Have you had a stroke or mini stroke in the past 6 months?
Yes
No
Unsure

9. Have you had a heart attack in the past 6 months?
Yes
No
Unsure
10. Have you been diagnosed with any end-stage disease? (e.g., cancer, renal failure,
COPD, liver disease)
Yes
No
Unsure

11. Have you been admitted to the hospital in the last 4 weeks?
Yes
No
Unsure

I agree that I have answered the questions above truthfully and to the best of my
knowledge.
X I AGREE

Thank you for participating in this survey! If you were not eligible for this study and the
survey ended, we appreciate you taking the time to answer our questions.
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If you did qualify to participate in the study, you will see the Heart Failure Survey in
your queue below. Please click on "Begin Survey" at the bottom of the page and complete
the entire survey to receive your $25 gift card. We are grateful for your time, answers, and
feedback and we look forward to furthering research.
If you have any questions, please reach out.
Sincerely,
Alex Ruppe, BSN, BSPH, RN
Cardiac Nurse
Ph.D. Candidate, Medical University of South Carolina College of Nursing
(803) 417-6635
moseleal@musc.edu

If you are having symptoms of depression or sad thoughts and would like to speak with
someone or get connected to a treatment center, the Substance Abuse and Mental Health
Services Administration (SAMHSA) Treatment Referral Hotline is free, and someone is
available to help 24/7. You can call the hotline at 1-800-662-HELP (4357).
If you are currently experiencing severe heart failure symptoms, please contact your
doctors about your symptoms. If you do not have a doctor or need help contacting yours, you
can reach out to me for assistance.
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Section 2: REDCap Survey – Single Item Literacy Screener, Demographics
Questionnaire, Feasibility and Acceptability Questions, Contact Information
ABOUT YOU
Single Item Literacy Screener (free for public use)
How often do you need to have someone help you when you read instructions,
pamphlets, or other written material from your doctor or pharmacy?
Never
Rarely
Sometimes
Often
Always
How old are you? (Please select your age from the drop-down)
What is your marital status?
Single
Married or living with a partner
Separated
Divorced
Widowed
Other
Prefer not to respond
How long have you been diagnosed with heart failure?
New diagnosis (< 3 months)
3 months - 12 months
1 year - 2 years
3 years - 4 years
5 years - 8 years
9+ years
Unsure
Prefer not to respond
How many children do you have? (please use the drop down to select the number of
children)
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How many people live in your household (including yourself)? (please use the drop
down to select the number of individuals)
What is the HIGHEST level of education you have COMPLETED?
No high school degree
High school degree or GED
Associates degree
Bachelor’s degree
Master’s degree
Doctoral degree
Prefer not to respond
What is your primary health insurance status?
None
Medicare
Medicaid
Public (from Healthcare Marketplace)
Private (from employer)
Other
Unknown
Prefer not to respond
How tall are you? (please use the drop down to select your height)
How much do you weigh (pounds)? (please use the drop down to select your weight)
Have you been diagnosed with any of the following? (Please check all that apply)
Hypertension (high blood pressure)
High cholesterol
Diabetes
Atrial fibrillation (abnormal heart rhythm)
Coronary Artery Disease (CAD)
Asthma
Chronic Obstructive Pulmonary Disease (COPD)
Obstructive Sleep Apnea (OSA)
None of the above
Unsure
What is your race and ethnicity? Select all that apply.
Black or African American
White
American Indian or Alaska Native
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Asian
Hispanic or Latino
How did you hear about this study?
I received an email or phone call.
I saw an ad on Facebook.
I saw a post within a Facebook group.
Someone told me about this study.
Other
How did you complete the survey questions?
I completed the survey questions online and on my own.
I completed the survey questions online with help from someone.
I answered questions over the phone, and the researcher filled out the questionnaires for
me.
Other
The way I was contacted about and/or found out about this study seemed like a good
match.
Completely disagree
Disagree
Neither agree nor disagree
Agree
Completely agree
I was easily able to access survey questions and follow survey instructions.
Completely disagree
Disagree
Neither agree nor disagree
Agree
Completely agree
The survey questions seemed fitting to me and my condition.
Completely disagree
Disagree
Neither agree nor disagree
Agree
Completely agree
I understood what the survey questions were asking.
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Completely disagree
Disagree
Neither agree nor disagree
Agree
Completely agree
The amount of time it took me to complete survey questions was acceptable.
Completely disagree
Disagree
Neither agree nor disagree
Agree
Completely agree
I was easily able to complete all the parts of this study.
Completely disagree
Disagree
Neither agree nor disagree
Agree
Completely agree
The gift card amount ($25) was an acceptable amount of reimbursement.
Completely disagree
Disagree
Neither agree nor disagree
Agree
Completely agree
The purpose of this study was explained to me in a way that I could understand.
Completely disagree
Disagree
Neither agree nor disagree
Agree
Completely agree
I welcomed the opportunity to share my symptom experience.
Completely disagree
Disagree
Neither agree nor disagree
Agree
Completely agree
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I would participate in a study such as this one again.
Completely disagree
Disagree
Neither agree nor disagree
Agree
Completely agree
I would recommend participating in a study such as this one to someone I know.
Completely disagree
Disagree
Neither agree nor disagree
Agree
Completely agree
I agree that I have answered the questions above truthfully and to the best of my
knowledge.
X I AGREE
Thank you for completing the survey!
Please provide your contact information after submitting your survey so we can
send you your $25 Amazon gift card.
Contact Information
Thank you for completing the survey portion of the study! Please provide your
contact information below so we can send you your $25 Amazon gift card.
Also, please let us know if you are interested in being contacted about participating
in an interview about your symptoms. Participants chosen to participate in
interviews will receive an additional $25 Amazon gift card once the interview is
completed. Interviews will be done over the phone or through Doxy.me at a time
most convenient to you. Please reach out if you have any questions.
What is your name?
What is your phone number?
What is your email address?
How would you like your $25 Amazon gift card to be sent to you?
Email
Text message
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Are you interested in being contacted for an interview (for an additional $25
Amazon gift card)?
Yes
No
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Section 3: Minnesota Living with Heart Failure Questionnaire
â

MINNESOTA LIVING WITH HEART FAILURE QUESTIONNAIRE
The following questions ask how much your heart failure (heart condition)
affected your life during the past month (4 weeks). After each question, circle the
0, 1, 2, 3, 4 or 5 to show how much your life was affected. If a question does not
apply to you, circle the 0 after that question.
Did your heart failure prevent
you from living as you wanted during
the past month (4 weeks) by -

No

1. causing swelling in your ankles or legs?
2. making you sit or lie down to rest during
the day?
3. making your walking about or climbing
stairs difficult?
4. making your working around the house
or yard difficult?
5. making your going places away from
home difficult?
6. making your sleeping well at night
difficult?
7. making your relating to or doing things
with your friends or family difficult?
8. making your working to earn a living
difficult?
9. making your recreational pastimes, sports
or hobbies difficult?
10. making your sexual activities difficult?
11. making you eat less of the foods you
like?
12. making you short of breath?
13. making you tired, fatigued, or low on
energy?
14. making you stay in a hospital?
15. costing you money for medical care?
16. giving you side effects from treatments?
17. making you feel you are a burden to your
family or friends?
18. making you feel a loss of self-control
in your life?
19. making you worry?
20. making it difficult for you to concentrate
or remember things?
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21. making you feel depressed?
0
1
2
3
4
5
________________________________________________________________________
_
©1986 Regents of the University of Minnesota, All rights reserved. Do not copy or
reproduce without permission. LIVING WITH HEART FAILURE® is a registered
trademark of the Regents of the University of Minnesota.
Instructions for Data Collection and Scoring
.
1.
Patients should respond to the questionnaire prior to other assessments and
interactions that may bias their responses. You might tell the patient that you
would like to get his or her opinion before doing your medical assessment.
2.

Ample, uninterrupted time should be provided for the patient to complete the
questionnaire. We recommend that the patient answer the questions without
being influenced by others such as their spouse or family members. Studies
show that patient proxies often have different perspectives.

3.

We recommend that you use the first question to give the respondent more
detailed instructions as follows.
a. Read the introductory paragraph at the top of the questionnaire.
b. Read the first question with the respondent – “Did your heart failure prevent
you living as you wanted during the last month (4 weeks) by causing swelling in
your ankles or legs?” Then tell the respondent If you did not have any ankle or leg swelling during the past month
(4 weeks) you should circle the zero (0) after this question.
If you did have swelling that was caused by a sprained ankle or some
other cause that you are sure was not related to heart failure, you
should circle the zero (0) after this question.
If you had swelling that might be related to your heart condition, then
rate how much the swelling prevented you from doing things you
wanted to do or feeling the way you would like to feel. In other
words, how much did the swelling affect your life? Circle either the 0,
1, 2, 3, 4 or 5 to indicate how much the swelling affected your life
during the past month – zero (0) means not at all, one (1) means very
little and five (5) very much.

4.

Ask the patient read and respond to all 21 questions. The entire questionnaire
may be read directly to the patient if one is careful not to influence responses by
verbal or physical cues.

5.

Check to make sure the patient has responded to each question. If a question
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does not apply to the patient they should circle the zero (0). Make sure there is
only one answer clearly marked for each question.
Instructions for Data Collection and Scoring (cont’d)
1.

Score the questionnaire by summating the responses to all 21 questions. In
addition, a physical dimension score (items 2, 3, 4, 5, 6, 7, 12, 13 on the version
sent with these instructions) and emotional dimension score (items 17, 18, 19, 20,
21) have been identified by factor analysis and may be scored by simple
summation to
further characterize the effect of heart failure on a patient’s life.

2.

Partially complete questionnaires do occur despite best efforts to minimize
missing data. However, missing data can greatly bias the data and complicate
analysis. To reiterate, you need to make sure the respondents understand to mark
zero for any items that do not apply to them, rather than leave a blank.
Whenever possible review the questionnaire before the respondent leaves to
make sure there are no unanswered questions or questions with more than one
answer.

3.

Several methods to impute missing data are discussed in the literature.1, 2
Multiple imputation using completed questions and perhaps other study
variables to predict missing responses should be considered.3 If a missing
response is not imputed, the item will be eliminated from that person’s score
(the sum of responses). Since intermittently missing data can greatly affect
within-person changes in scores, you might want to use the same subset of
questions to represent a person at all times by omitting questions that have
missing data at any point in time. We do not have any recommendations about
when missing data become too extensive to render the information being
collected useless.
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Section 4: Symptom Status Questionnaire – Heart Failure

Symptom Status Questionnaire-Heart Failure
Instructions: Please read each of the statements carefully, and then
circle the number that best describes your condition or how much you
were bothered by these symptoms

during past 4 weeks.
1. Did you have shortness of breath during day time?
0. No (If your answer is no—please go to question 2)
1. Yes (If your answer is yes—please fill out 1a, 1b, 1c)
1a. How often?
1) Less than once
per week

2) 1-2 times per
week

3) 3-5 times
per week

4)
Nearly
daily

1b. How severe?
1) Slight

2) Moderate

3) Severe

4) Very severe

1c. How much did it distress or bother you?
0) Not

1) A little bit 2) Somewhat 3) Quite a bit

at all

4)
Very
much

2. Did you have shortness of breath when you lay down?
0. No (If your answer is no—please go to question 3)
1. Yes (If your answer is yes—please fill out 2a, 2b, 2c)
2a. How often?
1) Less than once
per week

2) 1-2 times per
week

3) 3-5 times
per week

4)
Nearly
daily

2b. How severe?
1) Slight

2) Moderate
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3) Severe

4) Very severe

2c. How much did it distress or bother you?
0) Not at

1) A little bit 2) Somewhat 3) Quite a bit

all

4)
Very
much

3. Did you have fatigue or lack of energy?
0. No (If your answer is no—please go to question 4)
1. Yes (If your answer is yes—please fill out 3a, 3b, 3c)
3a. How often?
1) Less than once
per week

2) 1-2 times per week

3) 3-5 times 4)
per week Nearly
daily

3b. How severe?
1) Slight

2) Moderate

3) Severe

4) Very severe

3c. How much did it distress or bother you?
0) Not at all

1) A little bit 2) Somewhat 3) Quite a bit 4)
Very
much

4. Did you have chest pain?
0. No (If your answer is no—please go to question 5)
1. Yes (If your answer is yes—please fill out 4a, 4b, 4c)
4a. How often?
1) Less than once
per week

2) 1-2 times per week

3) 3-5 times 4)
per week Nearly
daily

4b. How severe?
1) Slight

2) Moderate

3) Severe

4c. How much did it distress or bother you?
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4) Very severe

0) Not at all 1) A little bit 2) Somewhat

3) Quite a bit 4)
Very
much

5. Did you have leg or ankle swelling?
0. No (If your answer is no—please go to question 6)
1. Yes (If your answer is yes—please fill out 5a, 5b, 5c)
5a. How often?
1) Less than once
per week

2) 1-2 times per week

3) 3-5 times 4)
per week Nearly
daily

5b. How severe?
1) Slight

2) Moderate

3) Severe

4) Very severe

5c. How much did it distress or bother you?
0) Not at 1) A little bit 2) Somewhat 3) Quite a bit 4)
all

Very
much

6. Did you have difficulty sleeping at night?
0. No (If your answer is no—please go to question 7)
1. Yes (If your answer is yes—please fill out 6a, 6b, 6c)
6a. How often?
1) Less than once

2) 1-2 times per

3) 3-5 times

week

per week

per week

4)
Nearly
daily

6b. How severe?
1) Slight

2) Moderate

3) Severe

4) Very severe

6c. How much did it distress or bother you?
0) Not at
all

1) A little

2) Somewhat 3) Quite a

bit

bit

4)
Very
much
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7. Did you have dizziness or loss of balance?
0. No (If your answer is no—just check No and stop here)
1. Yes (If your answer is yes—please fill out 7a, 7b, 7c)
7a. How often?
1) Less than once

2) 1-2 times per

3) 3-5 times

week

per week

per week

4)
Nearly
daily

7b. How severe?
1) Slight

2) Moderate

3) Severe

4) Very severe

7c. How much did it distress or bother you?
0) Not at
all

1) A little

2) Somewhat 3) Quite a

bit

bit

4)
Very
much

Copyright, 2014 Seongkum Heo, RN, PhD, Debra K. Moser, RN, PhD, and Terry Lennie, RN,

Scoring method and interpretation
1. Sum all scores of a, b, and c for each symptom. For example, dizziness score =
7a+7b+7c.
2. If any person did not experience the symptom give 0 for all the items of the symptom.
3. Thus, possible score range for each symptom will be 0 to 12. These 7 combined scores
will be used to get Cronbach’s alpha.
4. To get total symptom score, sum all the 7 combined scores. Thus, the total possible
score range is 0 to 84 (12*7).
5. Higher scores indicate more severe heart failure symptoms.
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Section 5: Personal Health Questionnaire – 8

Scoring

If two consecutive numbers are circled, score the higher (more distress) number. If
the numbers are not consecutive, do not score the item. Score is the sum of the 8
items. If more than 1 item missing, set the value of the scale to missing. A score of
10 or greater is considered major depression, 20 or more is severe major
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depression.
Characteristics

Tested on 1165 subjects with chronic conditions.
No. of
items

Observed
Range

Mean

Standard
Deviation

Internal Consistency
Reliability

Test-Retest
Reliability

8

0-24

6.63

5.52

.86

NA

Source of Psychometric Data
U.S. National Chronic Disease Self-Management Study. Study described in Ory
MG, Ahn S, Jiang L, et al. National study of chronic disease self-management: six
month outcome findings. Journal of Aging and Health. 2013 [in press].
Comments
This is an adaptation of the PHQ-9 scale. Since this scale is self-administered in our
studies, question #9, "How often during the past 2 weeks were you bothered by
thoughts that you would be better off dead, or of hurting yourself in some way?",
was deleted. This scale available in Spanish.
References
Kroenke K, Strine TW, Spritzer RL, Williams JB, Berry JT, Mokdad AH. The
PHQ-8 as a measure of current depression in the general population. J Affect
Disord. 2009; 114(1-3):163-73.
Razykov I, Ziegelstein RC, Whooley MA, Thombs BD. The PHQ-9 versus the
PHQ-8--is item 9 useful for assessing suicide risk in coronary artery disease
patients? Data from the Heart and Soul Study. J Psychosom Res. 2012; 73(3):163168.

This scale is free to use
without permission
Self-Management Resource Center
711 Colorado Avenue Palo Alto CA 94303 (650) 242-8040
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Section 6: Semi-structured Interview Guide
Symptom Experience Interview guide

Person
To get started, could you tell me a little about yourself so I can get to know you? (probes:
living situation, kids, marital status, job, education, etc.)

Great! Thank you for sharing. Now, let’s talk about your heart condition and symptoms. I
am very interested in how you experience and deal with your symptoms. You have heart
failure and having this disease may make you experience physical or emotional
discomforts. So, I would like to talk about your symptoms with you if you are
comfortable with that.

Perception
1. I would like you to think back to the last 4 weeks. What symptoms did you
experience related to your heart condition? (Probes: If you are having trouble
thinking of symptoms, I can give you examples: SOB during daytime or lying
down, fatigue or lack of energy (need to rest, difficulty with ADLS), chest pain,
leg or ankle swelling, difficulty sleeping, dizziness or loss of balance, little
interest/pleasure in doing things, feeling down/depressed/hopeless, feeling
worried, poor appetite or overeating, trouble concentrating, speaking slowly,
feeling restless)
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a. Do any of those symptoms happen together or at the same time? Do any of
them happen by themselves?
2. How did those symptoms make you feel? (probe: describe physically and
emotionally)
3. When you experience symptoms of heart failure, what does that mean to you?

Evaluation
4. Can you explain to me how severe your symptoms are?
5. How often do they occur? (probe: every day, every week, once a month?)
6. How much do they impact your daily life?
7. What do you think causes your symptoms?
8. Do you think your symptoms can be managed or treated?

Response
9. Let’s talk about how you respond to your symptoms. What do you usually do
when you are experiencing symptoms? (probes: What do you do when you have
symptoms that are getting worse? Do you respond to each symptom differently or
adjust your daily life? Do you change your behaviors, so you do not experience
them as frequently or severely? How do you know when to call the doctor? Do
you seek help when your symptoms get worse?)
10. Do you have a support system? (probe: does someone take care of you and make
sure you are OK or are you taking care of everyone in your house? Do you share
with loved ones how you are feeling? Do you feel you have someone to talk

176

when you are having a hard time with symptoms? Does talking about your
symptoms make you feel better?)
11. My last question for you is- Has there ever been a time when you hid your
symptoms from someone else or downplayed how bad they were? I will let you
think about it for a minute. It could be a family member, friend, in a social setting,
your nurses or doctors, etc. (probe: quiet time to reflect) If yes, could you tell me
about it? What was going through your mind and what things made you feel like
you needed to hide your symptoms?
12. Is there anything else you want to talk about?

Thank you for your answers. Before we finish, I would like to get some feedback about
your experience participating in this study and being interviewed. You can be forthright
with me. You will not hurt my feelings. We want to know anything we could have done
better.

Follow-up questions

1. What was your overall impression of the study?

2. Did you have any problems accessing links or answering survey questions online?

3. How did you like being interviewed on the phone / virtually?
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4. What did you think about the length of time it took you to participate in the study?

5. Did the interview questions seem like they were a good fit?

6. What did you like most about the study?

7. What did you like least about the study?

8. Do you have any recommendations on how we could change the study to make it
more appealing to you?

9. Anything else you want to add?

Thank you for participating! I really appreciate you. For your gift card, would you like it
to be sent to you by text or email? Okay, let me confirm your information with you.
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Appendix E: Qualitative Codes and Code Descriptions

Name

Description

COVID-19

The impact of COVID-19 on their family life, health, interaction
with healthcare team, feelings of isolation during quarantine, fears
around contracting virus with a chronic condition

Emotional

Emotional symptoms or feelings in general of how emotional

symptoms

symptoms interact with other symptoms

Fear

Expressing feelings of fear or being scared

Feeling like a

Feeling like a burden, not wanting to be a burden to others, or

burden, others

others watching and feeling sorry for them or treating them in a

feeling sorry for special way
them
Feeling mentally Expressing weakness relating to what they feel emotionally rather
weak

than physical weakness or fatigue

Frustration

Frustration with limitations or how someone treated them / what
they said to them

Hopelessness

Expressing feelings of not having hope, like they are desperate to
get better, but it is not working, or that there isn’t anything to do to
overcome the disease
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Name

Description

Sadness and

Feeling down, sad, or depressed

feeling depressed
Trouble focusing Expresses feelings of it being hard to focus or symptoms making it
hard to focus
Trouble sleeping Expresses having trouble sleeping, which may be related to other
symptoms experienced as well
Worry

Experiencing feelings of worry or anxiety

Financial stress

Insurance, hospitalizations, medications, not being able to work

Person /

Person variables ± demographic (Marital status, children, age, and

Demographic

SDOH> education, race/ethnicity, area of the U.S., insurance
status, etc.)

Physical

Experiencing physical symptoms and how those symptoms interact

symptoms

with one another or emotional symptoms

Chest pain

Pain or discomfort in the chest

Cough

Experiencing coughing, whether participant relates it to HF or
something else

Dizziness

Experiencing dizziness, loss of balance, or feeling lightheaded

Fatigue

Experiencing fatigue, tiredness, increased need to rest, feeling
weak physically
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Name

Description

Frequent

Need to urinate frequently

urination
Lower extremity Swelling or water retention in the legs, ankles, or feet
edema
Shortness of

Feeling short of breath, including dyspnea on exertion, nighttime

breath

dyspnea, orthopnea

GI symptoms

Symptoms related to GI and appetite

Quality of life

Health related quality of life

Effect on family Symptoms affecting family activities, being able to do things with
activities

their family

Impact on daily

Having trouble carrying out daily activities due to altered physical

life and physical functioning from symptoms
functioning
Support

Support from family, friends, church, etc. or lack there of

Spirituality

Expressing spirituality or religious beliefs and use of prayer

Symptom

The symptom experience includes an individual's perception of a

experience

symptom, evaluation of the meaning of a symptom and response to
a symptom.

Symptom

People evaluate their symptoms by making judgements about the

evaluation

severity, cause, treatability and the effect of symptoms on their
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Name

Description
lives (Dodd, 2001).

Severity

People evaluate how severe a symptom is. This also includes

evaluation

evaluation of the threat posed by a symptom, such as whether or
not it is dangerous or has a disabling effect (Dodd, 2001)

Cause evaluation People evaluate where the symptom is coming from or what is
causing the symptom
Symptom

Perception of symptoms refers to whether an individual notices a

perception

change from the way he or she usually feels or behaves.

Symptom

Responses to symptoms include physiological, psychological,

response

sociocultural
and behavioral components (Dodd, 2001).

Changing diet

Changing what they eat, seasonings and salt intake, fluid and water
intake

Fears of death

Mentioning feeling scared of death, not wanting to leave family
behind

Hiding or

Hiding or not fully telling others how they are feeling or what is

downplaying

occurring with their disease process. This can include downplaying

symptoms

how bad symptoms, or the disease is from others

Reducing

Changing activity level based on what symptoms they are

activity level

experiencing or trying to avoid feeling symptoms they know occur
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Name

Description
when they overwork themselves

Seeking help,

Reaching out to their doctor when noticing a change in symptoms

doctor, hospital

or seeking help by visiting the doctor or hospital
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Dissertation Proposal: A Mixed Methods Approach to Symptom Clusters in
Black Women with Heart Failure Preserved Ejection Fraction: A Feasibility
Study

SPECIFIC AIMS
Patients with heart failure (HF) have a complex and multi-factorial symptom
experience that makes symptom self-monitoring and self-management difficult (1-4).
Four out of five patients with HF are hospitalized each year with exacerbations that could
be avoided with early detection (1). Heart failure symptoms can be clustered together into
symptom clusters to potentially assess risk of exacerbation and allow symptoms to be
identified early, monitored, and managed as a cluster (2, 5-21). However, there are
several notable gaps in existing HF symptom cluster studies. In a review of the literature,
no studies using qualitative or mixed methods (MM) were identified (5-21). While it is
known that females with HF have a greater symptom burden, few HF symptom cluster
studies have addressed sex differences (2-21). Females experience worse quality of life
(QoL) and functional impairment, and have higher rates of edema, depression, exercise
intolerance, and dyspnea on exertion compared to males (3, 4). Females with HF are
diagnosed or referred to cardiologists later than males and disproportionately receive
fewer recommended therapies or less self-management education (22-24). There is a
critical need to identify sex specific symptom clusters for females with HF. Additionally,
HF symptom cluster research lacks racial/ethnic diversity, with the majority of U.S.
studies contain at least 70% White participants, despite Black Americans having a 50%
higher incidence of HF (7-9, 11-14, 20). There is especially a need for explaining racial

185

disparities in patients with HF preserved ejection fraction (HFpEF), a type of HF caused
by diastolic dysfunction in which relaxation of the left ventricle is impaired from
increased stiffness (25, 26). Black Americans with HFpEF tend to be younger, report
worse QoL, and have a greater risk of hospitalization than White patients (26).
The long-term goal of this research is to examine the symptom experience of
Black women with HFpEF and how symptoms cluster in this population. Achievement of
this goal could lead to improved education for HF symptom self-management and selfmonitoring. The purpose of this MM study is to 1) assess the feasibility and acceptability
of this proposed study protocol and procedures for ascertaining symptom clusters in
Black women with HFpEF and 2) preliminarily analyze and integrate quantitative and
qualitative results (27). This purpose stems from the following research question: What
is the feasibility and acceptability of study processes, resources, and human and data
management of a convergent MM study of symptom clusters in Black women with
HFpEF? (27, 28). The rationale for this study is that determining feasibility and
acceptability for recruitment and implementation in a population that is underrepresented
in current HF symptom cluster research is a necessary first step to achieving the longterm research goal. If deemed feasible and acceptable, the proposed study will illuminate
the experiences of those who are underrecognized, undertreated and have a greater
symptom burden, and an MM approach allows for a more comprehensive examination of
the HF symptom experience (3, 4). Black female participants with HFpEF will be
recruited from Facebook across the U.S. Participants (n=50) will be administered the
Minnesota Living with HF Questionnaire (MLHFQ), a 21-item health related QoL
instrument, the Symptom Status Questionnaire-Heart Failure (SSQ-HF), which asks
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about the presence, frequency, severity, and distress of 7 physical HF symptoms in the
last 4 weeks, and the Personal Health Questionnaire Depression Scale (PHQ-8), which
asks about the frequency of 8 depressive symptoms over the last 2 weeks (2, 11, 29, 30).
Individual, semi-structured interviews guided by qualitative description will be conducted
with at least 15 participants to examine the symptom experience of Black women with
HFpEF (31-34). The interview guide follows the Symptom Management Model (SMM)’s
symptom experience dimension and person domain, while also integrating domains of the
MLHFQ (35, 36). After results are analyzed, common concepts will be compared through
simultaneous integration to create a comparative joint display to represent findings (28,
37). This application addresses the following specific aims:
AIM 1: Determine feasibility and acceptability of conducting a convergent mixed
methods symptom cluster study with a population of Black females with HFpEF (27).
AIM 2: Explore preliminary HF symptom clusters of physical and
psychological/emotional symptoms by cluster analysis of data collected from MLHFQ,
SSQ-HF, and PHQ-8 respondents(n=50) (29, 30, 36).
AIM 3: Explore the SMM’s symptom experience dimension and person domain
using 15 individual, semi-structured interviews guided by qualitative description (32, 35).
AIM 4: Integrate qualitative themes and quantitative symptom data to examine
confirmation, expansion, and discordance of results (28).
IMPACT: The National Institute of Nursing Research (NINR) highlighted symptom
cluster research as a critical component to advancing symptom science (11). The
proposed study will provide valuable insights for recruiting a high-risk and understudied
population and determining barriers to success for an MM HF symptom cluster study.
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The proposed study would also improve research efforts for the health of women by
considering sex and gender influences, a specific goal of the 2019-2023 Trans-NIH
Strategic Plan for Women's Health Research (38).
A. SIGNIFICANCE
Heart failure (HF) is a severe cardiovascular disease in which up to 30% of patients die
within 1 year after diagnosis (3, 23). HF is the most common cause of hospitalization in
the U.S. for those over the age of 65 and almost 1/4th of patients with HF will be
readmitted within 6 months after discharge (39). Inpatient hospitalizations for HF cost
over $30 billion a year, accounting for over 60% of total HF related costs in the U.S.
(40).
A1. Burden of HF symptoms in females: The lifetime risk for developing HF is 1 in 5
for both males and females, yet on average, less than 25% of females are included in HF
clinical trials, and females often do not receive the same recommended therapies as men
(23). HF is especially burdensome for females, who report poorer health, more
depression, worse quality of life and symptom severity, and more frequent and longer
hospitalization than males (1, 17, 23, 41, 42). HF with preserved ejection fraction
(HFpEF) is more prevalent in females, by a factor of 2 in some studies (23). This type of
HF is poorly understood, and more research is needed to characterize the symptom
experience (23, 26).
A2. Greater risk and worse outcomes for Black patients with HF: Black Americans
are 1.5 times more likely to develop HF compared to White Americans and at a 2.5 times
greater risk of dying from HF compared to White Americans (43). Black females have
the highest death rate from HF (80.4 per 100,000) compared to white and Hispanic
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females (75.3 and 47.0 per 100,000, respectively) (3). Black Americans also often have
difficulty recognizing and interpreting symptoms (43). This can lead to delays in seeking
treatment and ultimately result in avoidable hospitalizations from HF exacerbations (43).
This cascade of events is why understanding the symptom experience and how symptoms
cluster for Black females with HFpEF is necessary.
A3. Symptom clusters in HF: A symptom cluster is two or more symptoms that occur
simultaneously in a disease (2, 34). Knowledge about how symptoms cluster can help
patients to more easily recognize impending exacerbations, be used for developing more
targeted and effective interventions, and assist in determining risk for adverse health
outcomes (2, 5-21). A small body of literature exists for HF symptom clusters that
validates these potential uses (2, 5-21). However, research that has been conducted in this
area minimally examines sex differences, does not include qualitative methodologies, and
lacks racial and ethnic diversity (2, 5-21). Since few Black females have been included in
HF symptom cluster research, it is first necessary to determine if it is feasible to recruit
this population, what barriers and facilitators to adequate recruitment exist, and
participants’ willingness to participate in research studies (27). Qualitative methods are
needed to explore the intersection of gender, sex, and race and impact on the symptom
experience, as quantitative instruments alone have limited ability in encompassing such
factors. Studying the symptom experience and symptom clusters in relation to gender,
sex, race, and type of HF is warranted considering the increased burden of HF symptoms,
greater risk, and worst outcomes in females, Black Americans, and patients with HFpEF
(1, 17, 23, 42, 43).
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A4. The intersection of sex/gender, race/ethnicity, and health: Sex/gender and
race/ethnicity have a complex interaction that influences health and should be considered
when studying symptoms (44). Many factors contribute to the health disparities and
worse outcomes that are evident for multiple conditions, such as societal and cultural
stressors. This study aims to examine how the intersection of such factors can impact
symptom clusters and the symptom experience of Black women with HFpEF using mixed
methods (MM). Sex and gender differences in symptom perception and impact are also
prevalent in other chronic diseases. Females with Chronic Obstructive Pulmonary
Disorder report higher levels of anxiety and depression, worse quality of life, worse
perceived control of symptoms, and greater functional impairment (45-48). Women are
noted to have increased pain sensitivity and risk, and women with Chronic Venous
Disease were found to have worse neuropathic pain (burning, throbbing, and night
cramps) compared to males (49). Woman gender in asthma is associated with more
severe symptom intensity, frequency, and limitations from symptoms, and women with
asthma report poorer quality of life (50). This evidence supports the need for sex/gender
specific exploration of symptom clusters and the
symptom experience.
B. INNOVATION AND CONCEPTUAL FRAMEWORK
B1. Innovation: Current HF practice paradigms diagnose and treat males and females
using the same guidelines, despite growing evidence of differences in symptom
expression, burden and quality of life by sex (1-4, 23). This study is innovative in that
it seeks to shift this paradigm by placing an emphasis on sex and race that was
consistently lacking in a review of the literature (21). This will be done by initially
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exploring the symptom experience and symptom clusters for Black females with HFpEF
using MM. The convergent MM design is a novel approach to HF symptom cluster
research that, to our knowledge, has not been conducted before. Utilizing MM allows for
a more comprehensive exploration of the HF symptom experience and symptom clusters
for Black women. Symptom clusters are created based on data from questionnaires,
which have a limited ability in assessing personal factors and symptom perceptions,
evaluations, and responses. Individual, semi-structured interviews guided by qualitative
description allow for a straight description of the symptom experience as described by
participants (31-34). Examining study feasibility is needed for understanding the nuances
of recruitment and data collection within a population of Black females with HFpEF and
validation of the SSQ-HF in this population (27). A review of HF symptom cluster
literature revealed that of the eight studies conducted in the U.S., five had >70% white
participants, and the SSQ-HF has not been well validated in a Black population (7-9, 1114, 20, 29). Findings from this study could potentially improve inclusion of the
population in future research, thus increasing generalizability of HF symptom cluster
research long-term.
B2. Conceptual Framework: The Symptom Management Model (SMM), based on the
Symptom Management Theory (SMT), highlights the multi-faceted nature and complex
interactions of symptom components (35). Symptom experience, components of
symptom management strategies, outcomes and symptom status, person, environment,
and health and illness are the six components that comprise the SMM (35). For the
present study, symptom experience and person influence the semi-structured interview
guide, as these components are well suited for individual interviews, best answer the
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overall research question, and were chosen because they allow for exploration of
demographic, psychological, and sociological factors that can influence the symptom
experience of a Black woman with HFpEF (35). These components will also guide
content analysis of interview data and the triangulation of questionnaire and interview
results (35). The three domains of the MLHFQ (physical symptoms, emotional
symptoms, and QoL) also influenced interview guide questions, which sets the stage for
merging of quantitative and qualitative results (28, 36).
C. APPROACH
C1. Design Overview: d
C2. Preliminary studies: In an integrative review of HF symptom cluster science, the PI
noted the following prominent findings (21). Current research has validated the existence
of HF physical symptom clusters and emotional/psychological symptom clusters and has
shown that physical symptoms can cluster with emotional/psychological symptoms (2, 57, 9, 10, 20, 13-16, 19). One study found identical symptom clusters for males and
females; however, females reported significantly higher distress from symptoms (12).
Those who were younger reported more psychological and emotional distress, with no
relation to actual severity, and higher education levels were associated with lower
symptom severity (5, 8, 9, 11, 19). Symptom clusters can also be used to assess risk of
mortality, disease-specific health status, cardiac event-free survival, cardiac event risk,
and predicted hospitalization (6-8, 10, 12, 18, 19). The literature also supports the
importance of recognizing emotional/psychological symptoms in patients with HF, as
they can be the most distressing of HF symptoms and result in the highest risk for adverse
outcomes (5, 6, 9, 10, 12-14, 17, 20).
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C3. Setting: The study population will be recruited through Facebook using ads and
posts within Facebook groups.
C4. Inclusion/exclusion criteria: Inclusion criteria include being a Black female with a
self-reported diagnosis of HFpEF (ejection fraction greater than or equal to 50%).
Participants must be in the age range of 35 to 74 years old. This age range was
determined after a consultation with the dissertation committee HF expert to be
representative of most females with HF, while excluding ages that are more likely to
result in outliers. Exclusion criteria include having a diagnosis of a severe or end-stage
disease, stroke or myocardial infarction in the last 6 months, hospitalization in the last 4
weeks, or if the patient is currently experiencing a HF exacerbation that requires
hospitalization.
C5. Recruitment and retention: After receiving IRB approval, participants will be
recruited using Facebook posts and ads. Facebook respondents will self-report a
diagnosis of HFpEF from a healthcare provider and state their ejection fraction to
determine eligibility. Electronic flyers will be distributed via email or Facebook, and will
contain study purposes, contact info, a link to the REDCap® screening questionnaire, and
will offer an amazon electronic gift card. Participants will also be called to complete
screening via phone if interested. If eligible, the PI will provide a link to the REDCap®
survey. All survey respondents will be asked about interview participation interest and
contact preferences. The PI will reach out to all participants interested in scheduling an
interview and will coordinate a time that works best for the subject for informed consent
and interviews via phone. Participants will also have the option to meet virtually through
a free and HIPAA compliant platform if they have the technological capability.
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D. AIM 1: FEASIBILITY Determine feasibility and acceptability of conducting a
convergent mixed methods symptom cluster study with a population of Black
females with HFpEF (27).
D1. Sample size: This study will utilize purposive sampling to ensure the inclusion of
only Black women with HFpEF (52). To determine the sample size for the feasibility
study, Leon, Davis, and Kraemer propose a pragmatic approach based on recruitment and
needs for establishing feasibility (53). We estimate it will take approximately 2 hours to
recruit each potential participant, including calling or emailing the participant, leaving a
voicemail, follow-up calls, screening, etc. Further assuming that the PI will be able to
spend approximately 25 hours per week (~100 hours a month) actively recruiting, this
would result in approximately 50 potential participants a month. If 20% of participants
agree to participate, that would result in 10 enrolled participants a month. Since the study
is being conducted over 5 months, this would result in a sample size of 50 participants.
Therefore, feasibility data will be collected for at least 50 participants.
D2. Variables: Consent rate, recruitment rate, interview interest rate, survey completion
rate, feasibility/acceptability scores, data collection time for interviews, recruitment
burden, transcription time, software reliability, adverse patient events,
inclusion/exclusion criteria, semi-structured interview questions adequate for answering
research question, triangulation of quant and qual results
D3. Procedures: Participants fitting the inclusion criteria will be recruited as previously
described. To further determine eligibility, the screening form within REDCap® will be
accessed and completed by the participant via a link or by the PI in the case of a
participant phone call. All screening data will be saved, regardless of whether the patient
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is eligible for study participation, for feasibility purposes of assessing inclusion/exclusion
criteria. Participants will be asked to provide consent to be contacted for questionnaire
and interview portions and to signify their contact preferences. If the patient is deemed
eligible for study participation after screening, the PI will provide a link for REDCap®
questionnaires or determine a time that works best for the participant to complete aspects
of the study via phone. Demographic information will be collected using the REDCap®
demographic questionnaire and participants will complete the questionnaires. If the
participant is completing study aspects over the phone with the PI, notes will be
transcribed to capture the approximate time for completion and any verbalized or
observed problems with instrument items or instructions. Following questionnaire
completion, participants will be asked if they are interested in participating in an
interview. The PI will select participants based on the sampling frame and conduct semistructured interviews using the interview guide. After the questionnaires are administered
and/or the interview is completed, the AIM and FIM questionnaires will be administered
to assess participant acceptability and feasibility (51). Feasibility and acceptability
measures will be recorded in Excel throughout the entire process. These measures include
whether approached subjects agree to participate, number of participants recruited each
week and month, completion rate of MLHFQ, amount of time it takes to complete each
aspect and the study and total time for all components, functionality and acceptability of
data collection platforms.
D4. Data management: All questionnaires will be developed using MUSC’s REDCap®
application and will be stored on REDCap®’s secure, password-protected server. To
minimize risk of missing data, the survey within REDCap® will not allow submission

195

unless every questionnaire item has an answer. An item can only be skipped if a
participant explicitly refuses to answer. In this case, the PI will record a 9 on the
questionnaire in REDCap®. Data will remain in REDCap® until analysis, during which
it will be exported to SPSS. No patient identifiers will be exported to SPSS and only
dissertation committee members will have access to participant data. Exporting of data
will be tested before study employment to ensure consistent data formatting. Data on
feasibility and acceptability variables will be stored in a secure, password-protected BOX
folder on MUSC’s server.
Data analysis. The feasibility of study processes, resources, and human and data
management will be analyzed as the primary aim of this study (27). The consent rate will
be determined by calculating the percentage of eligible participants who consent by
completing the next survey, with a goal consent rate of >90%. The recruitment rate will
be determined by calculating the percentage of participants successfully recruited out of
the recruitment goal. Recruitment of >85% of the 50 participants goal is the benchmark.
The interview interest rate will be determined by calculating the percentage of
participants who indicate interest in being interviewed, with a goal interview interest rate
of >30%. Surveys will be examined for missing data and the percentage of surveys with
missing data will be calculated. The survey completion rate goal is >85% fully completed
surveys. The feasibility and acceptability question results will be analyzed by calculating
a mean score. A mean score of 3 or greater on a scale of 0-5 will support participant
acceptability and feasibility. Time to complete interviews will analyzed by calculating the
mean and range of interview length. The goal interview length time will be less than 1
hour per interview. Time spent recruiting each week will be tracked and averaged per
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week, with a goal of <20 hours spent per week recruiting. Time spent editing transcripts
for accuracy will be tracked and averaged, with a goal of <2 hours per interview.
Software reliability and adverse patient events will be tracked, with the goal of no major
events.
E. AIM 2: QUANTITATIVE Explore preliminary HF symptom clusters of physical
and psychological/emotional symptoms by completing cluster analysis of data
collected from MLHFQ, SSQ-HF, and PHQ-8 respondents (n=50) (29, 30, 36).
E1. Sample Size Consideration: Sampling method and size for the quantitative portion
of the study are the same as previously described for the feasibility aim. A sample size of
50 Black females with HFpEF will allow for preliminary clustering of symptoms within
this feasibility study.
E2. Variables: MLHFQ physical symptoms (edema, fatigue/increased need to rest,
fatigue/low energy, shortness of breath, sleep difficulties), emotional/psychological
symptoms (worrying, feeling depressed, cognitive problems), QoL score, SSQ-HF
symptoms (presence, frequency, severity and distress of shortness of breath, orthopnea,
fatigue, chest pain, lower extremity swelling, difficulty sleeping, dizziness or loss of
balance), PHQ-8 responses, age, self-reported ejection fraction, length of time diagnosed
with HF, marital status, number of children, household number, highest level of
education, height, weight, body mass index, presence of co-morbidities (hypertension
(HTN), high cholesterol (HLD), diabetes mellitus (DM), atrial fibrillation (AFIB),
coronary artery disease (CAD), asthma, COPD, obstructive sleep apnea (OSA)
E3. Procedures: Demographic and clinical features on each participant will be collected
and analyzed using a combination of the screening form and a demographic
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questionnaire, which include the variables listed above. Comorbidity diseases were
chosen due to commonality in patients with HF and their potential impact on HF
symptoms (2, 5-21). The questionnaires will be administered to participants before
qualitative interviews to minimize bias (36). The MLHFQ is a quality-of-life
questionnaire designed for patient with HF in 1984 by Rector and Cohn (36). The
questionnaire includes 21 questions related to the impact of physical symptoms,
emotional/ psychological symptoms, and HF related activities on daily life (36). To
complete the questionnaire, the participants rate how much an item affected their life in
the past month (4 weeks) using a Likert scale of 0-5 with 0 indicating none, 1 very little,
and 5 very much (36). The total score ranges from 0 to 105, with a higher scoring
indicating worse quality of life and more impact from symptoms and components of HF.
The MLHFQ has excellent internal consistency with a Cronbach’s α usually ranging from
0.89-0.96 and has shown success in forming symptom clusters in multiple other HF
symptom cluster studies (2, 5-7, 9, 17, 18, 20, 36). The questionnaire is short, easy to
administer, and has been validated for its psychometric properties (2, 5-7, 9, 17, 18, 20,
36). The domains of the MLHFQ align with study aims and are also implemented in
qualitative interviews for data collection consistency. The SSQ-HF is a HF symptom
scale established in 2015 that measures the presence, frequency, severity, and distress of
7 physical symptoms mostly commonly reported in HF in the last 4 weeks (29). If a
symptom is present, the respondent then rates frequency, severity, and distress using a
Likert scale of 1-4, with 1 being less and 4 being most (29). The Cronbach’s α for the
SSQ-HF is 0.80 and matches the time frame of the MLHFQ (29, 36). The PHQ-8 asks
respondents to rate severity of 8 depressive symptoms from 0, not at all, to 3, nearly
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every day, over the past 2 weeks (30). This depressive symptom scale is widely used and
has a Cronbach’s α of 0.83 (30). The participants will read instructions and complete the
questionnaires via the REDCap® link, or the PI will read questionnaire items to the
participant and record answers in REDCap®.
E4. Data management: Data management practices for the quantitative aim are the same
as previously described for the feasibility aim.
Demographic and clinical data analysis. Demographic and clinical variables will be
analyzed within SPSS for frequencies and valid percentages and means and standard
deviations for descriptive statistics. Results will be displayed in a demographics table.
Cluster analysis. A hierarchical cluster analysis will be used to explore preliminary
symptom clusters of physical and emotional/psychological symptoms included in the
MLHFQ, SSQ-HF, and PHQ-8 (29, 30, 36, 54, 55). The hierarchical cluster method was
chosen because it can be used to cluster variables (symptoms) rather than just cases
(study participants) (54, 55). It also allows the researcher to select the best number of
clusters after running the analysis rather than having to define the number of clusters at
the start, such as in K-means clustering (54, 55). Hierarchical clustering creates compact
and homogenous clusters and differences in clusters are maximized (2, 9, 54, 55). The 3
main steps to hierarchical clustering are to calculate distances between variables, link
clusters, and then determine the right number of clusters based on dendrogram results
(55). For this study, each variable (symptom) will be placed in a separate column and
participant data (responses to the questionnaire) will be placed across each row within
SPSS and a hierarchical cluster analysis will be run. The analysis will be conducted by
clustering variables (symptoms). Therefore, all questionnaire items that represent the
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symptoms will be selected as the variables for the analysis. In plots, the dendrogram
option will be selected. A dendrogram is a tree like structure that shows a graphic
visualization of how clusters are related (55). Branches are based on semi-partial rsquared scores and smaller branches signify more similar clusters (55). All variables will
be merged into a single cluster at the start since this is an exploratory analysis and the
best number of clusters is unknown. Next, Euclidean distance is the selected method for
calculating distance, and it determines which cases are most similar by calculating the
square root of the sum of squared distances (55). This method is commonly used for
interval level data and places an emphasis on larger distances since it is squared. For
clustering method, the ultimate goal is to use Ward’s method of clustering, as it is best for
maximizing significant differences between clusters by using the F value (55). However,
single-linkage clustering is best for identifying outliers. Therefore, a single-linkage
analysis will be run first to remove outliers and then Ward’s method will be used once
outliers are removed. The PI will confer with the research team statistician to determine
best number of cases by visually examining the dendrogram for dissimilarity between
clusters and drawing a cut-off line (55). The analysis will then be repeated, specifying
number of cases at the start.
F. AIM 3: QUALITATIVE Explore the SMM’s symptom experience dimension and
person domain using 15 individual, semi-structured interviews guided by qualitative
description (31, 36).
F1. Sample Size: The goal sample size for interviews is 15. We will assess for data
saturation during the qualitative data analysis of interviews.
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F2. Recruitment and retention: A purposive sampling strategy will be used to recruit at
least 15 Black females with HFpEF for the individual, semi-structured interviews. The PI
will reach out to all individuals interested in being interviewed to ensure every participant
who wants to be interviewed has the opportunity.
F3. Variables: Codes and themes derived from the qualitative analysis will be grouped
within SMM’s symptom experience dimension and person domain and MLHFQ
domains.
F4. Procedures: Individual interviews will be conducted via a free HIPAA compliant
videoconference platform, or via telephone if unable to complete through
videoconference. The PI will ask participants open-ended questions in a semi-structured
interview format about their personal background (e.g., living situation, kids, marital
status, job, education) and symptom experience. The interview guide was developed by
combining components of the SMM and domains of the MLHFQ (35, 36). An interview
guide facilitates consistency in data collection while also allowing for unanticipated
responses (31). Participants will be asked to describe their symptoms in the last 4 weeks
to correspond with the MLHFQ symptom recall time frame (36). Probes, both
questioning and silent, will be used to facilitate thoughtful responses from participants
(31). Mirroring during interviews will be utilized to ensure the PI is capturing the true
perspective of each participant (31). Individual interviews allow participants to freely
share their experience while maintaining confidentiality and allows for higher credibility
and validity than focus groups (31).
F5: Data management: Interview audio will be recorded directly on the mobile device
being used for the clearest sound quality, and transcribed verbatim. An encrypted, secure,
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and HIPAA compliant platform will be used for interview transcription. The PI will
confirm the accuracy of transcriptions for all interviews and make edits as needed. The
audio recordings and transcripts will be kept in a password protected, electronic folder in
MUSC’s BOX per IRB requirements. Audio recordings will be destroyed once
transcriptions are complete to protect the identity of participants. After transcription,
NVivo® will also be used to support thematic coding and analysis by the PI in
consultation with dissertation chair (Dr. Magwood, Professor, MUSC) and committee HF
expert (Dr. Dunbar, Professor, Emory University).
Data analysis. Qualitative description will guide qualitative analysis of interview data
(31-34). The PI will first read through transcripts completely and highlight identified text
that may represent aspects of the symptom experience phenomenon (34). This first step is
meant to increase trustworthiness by not allowing broad code structures to result in the PI
missing important findings that do not fit within the selected frameworks (34). A directed
approach to content analysis will then be used with SMM components and MLHFQ
domains as broad code types to guide development of sub-codes (34-36). Interviews will
be transcribed and analyzed as they are collected using a constant comparative method
(31). Two to three transcripts will be analyzed at a time and then codes will be revised as
needed (31). The PI will keep a detailed audit trail throughout data collection and
analysis to support dependability (31). A detailed audit trail will be valuable in ensuring
reproducible methods in a future study (31). The PI has personal experiences from caring
for Black females with HF. Therefore, bracketing of those experiences is required before
beginning data collection or analysis to increase objectivity (31).
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G. AIM 4: INTEGRATION OF RESULTS FROM AIM 2 AND 3 AIM 4: Integrate
qualitative themes and quantitative symptom data to examine confirmation,
expansion, and discordance of results (28, 37).
G1. Procedures: Quantitative data and qualitative data will be collected simultaneously
and analyzed separately, as previously described (28). Results from will then be merged
through triangulation with the components of the SMM and MLHFQ (28, 35, 36).
G2. Data management: Quantitative and qualitative data will continue to be managed as
previously described. Data integration files will be stored in a secure, password-protected
BOX folder on MUSC’s server.
Data analysis. Preliminary symptom clusters and interview themes will undergo
simultaneous integration (28). This involves first identifying common concepts. Common
concepts will be identified by triangulating results with SMM components and MLHFQ
domains (28, 35, 36). Common concepts will then be compared and contrasted to
determine how results interact (28). Outcomes from the MM analyses will be used to
interpret and explain the convergence or divergence in the results (28). This analysis will
provide a richer understanding of the symptom clusters and the symptom experience.
Findings will be represented using a comparative joint (28, 37).
H. POTENTIAL PROBLEMS, ALTERNATIVE STRATEGIES, AND
BENCHMARKS FOR SUCCESS
H1: Challenges in mixed methods design: MM requires skills and experience with both
quantitative and qualitative data collection and analysis, which is challenging for any
researcher, especially a novice. However, the dissertation team behind this proposed
study has immense experience across a wide spectrum of specialties, and their expertise
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will be essential to the success of this study. MM studies also require considerable time
and resources. Timeliness is essential, and the PI will continually analyze qualitative data
while still conducting other study aspects. Also, integration of results is another skill set
and will require considerable time, effort, and collaboration with the dissertation
committee.
H2: Recruitment challenges: Due to COVID-19, face-to-face interactions are not
currently possible. Recruiting via electronic flyers and calls can be challenging in
establishing trust. Recruitment strategies include tailored social media ads using
Facebook Ad Manager and collaborating with admins of HF support groups on
Facebook. Participants would complete the survey via a REDCap® link and provide their
phone number if interested in being contacted for an interview. Snowball sampling could
be used to allow participants to share the ad with others that may qualify. Facebook ad
manager would allow for detailed tracking of recruitment efforts to support the feasibility
aim. The challenge that arises from this recruitment strategy is using self-report of
HFpEF diagnosis from participants. HFpEF is a complex disease process that providers
themselves find difficult to diagnosis (57). Asking participants to self-report their
diagnosis is inferior to a confirmed diagnosis from a medical chart.
H3: Generalizability: This study aims to assess the feasibility of an MM study. A
sample size of 50 is adequate for fulfilling feasibility aims; however, the sample size is
not adequate to form significant symptom clusters. Future research will be needed to
create generalizable symptom cluster evidence.
H4: Future research: If this study shows promise of feasibility, future research will
include conducting a full MM research study. With a clear and validated study protocol
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and plan, a full study could create new evidence for the symptom experience and
symptom clusters for Black women with HFpEF. Findings could be used to create
tailored symptom education and self-management strategies for this high-risk population.
H5: Benchmarks for success:
Feasibility Outcomes
Feasibility component

Indicator

Criteria

Process
Consent rate

% of eligible participants

>90% consent rate

consented by completing
next survey
Recruitment

% of participant recruitment

>85% of recruitment

goal

goal (goal N=50 for
survey, goal N=15 for
interview)

Interview interest rate

% of participants interested

>30% interview interest

in an interview
Survey completion rate

% of completed surveys

>85% fully completed
surveys

Feasibility /

Average scores ranging from

Average score of 4 or

acceptability scores

1-5

higher

Resources
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Data collection time -

Interview duration average

< 60 minutes

Time spent with recruitment

< 20 hours

Interview
Recruitment burden

/ week
Management
Transcription time

Time spent with transcription < 2 hours / interview
/ editing transcripts

Software reliability

Issues with software / data

No major events

management platforms
Adverse patient events

Adverse events during data
collection
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No major events
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PROTECTION OF HUMAN SUBJECTS

The proposed study qualifies for Institutional Review Board (IRB) exempt review
categories 2 and 4. Feasibility, questionnaire and interview data will be collected and
analyzed from participants. Medical University of South Carolina (MUSC)’s IRB will
serve as the main governing body from which the primary investigator (PI) will seek IRB
approval.
Risks to Human Subjects
There is minimal risk to human subjects for the proposed study. Purposive
sampling will be used to recruit a minimum of 50 participants from Facebook and word
of mouth.
Inclusion criteria: female sex, woman gender, Black race, a confirmed or selfreported diagnosis of heart failure preserved ejection fraction, English speaking, and 35
to 74 years old.
Exclusion criteria: a diagnosis of an end-stage co-morbidity, stroke or myocardial
infarction in the last 6 months, and currently experiencing an HF exacerbation that
requires immediate hospitalization.
After receiving IRB approval, participants will be recruited using Facebook posts
and ads. Facebook respondents will self-report a diagnosis of HFpEF from a healthcare
provider and state their ejection fraction to determine eligibility. Electronic flyers will be
distributed via email or Facebook, and will contain study purposes, contact info, a link to
the REDCap® screening questionnaire, and will offer an amazon electronic gift card ($25
for completing the questionnaire and $25 for completing the interview). Participants will
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also be called to complete screening via phone if interested. If eligible, the PI will
provide a link to the REDCap® survey. All survey respondents will be asked about
interview participation interest and contact preferences. The PI will reach out to all
participants interested in scheduling an interview and will coordinate a time that works
best for the subject for informed consent and interviews via phone. Participants will also
have the option to meet virtually through a free and HIPAA compliant platform if they
have the technological capability.
First, demographic information will be collected with a questionnaire in
REDCap®, where it will be stored on the secure and password protected server. Next, the
PI will administer the Minnesota Living with Heart Failure Questionnaire (MLHFQ). The
MLHFQ includes 21 questions related to the impact of physical symptoms,
emotional/psychological symptoms, and HF related activities on daily life. To complete
the questionnaire, the participants rate how much an item affected their life in the past 4
weeks using a Likert scale of 0-5 with 0 indicating none, 1 very little, and 5 very much.
The questionnaire will be administered to a minimum of the 50 participants. Next, the PI
will administer the Symptom Status Questionnaire-Heart Failure (SSQ-HF). The SSQ-HF
asks about the presence, frequency, severity, and distress of 7 HF symptoms in the last 4
weeks using a Likert scale of 1-4 if a symptom is present with 4 being the most frequent,
severe, or distressful. Next, the PI will administer the Personal Health Questionnaire
Depression Scale (PHQ-8). The PHQ-8 asks about the frequency of 8 depressive
symptoms over the last 2 weeks using a Likert scale of 0-3, with 0 being not at all and 3
being nearly every day. Individual, semi-structured interviews will be conducted with at
least 15 participants who agree to be interviewed after responding to the questionnaires.

215

Interviews will also be conducted by telephone or via a HIPAA compliant platform at a
time most convenient to the participant. The PI will ask participants open-ended
questions about their sociocultural and demographic background and symptom
experience. Participants will be asked to describe their symptoms and their response to
symptoms in the last 4 weeks. After the MLHFQ is administered and the interview is
complete, participants will be asked questions about feasibility and acceptability of the
study protocol. It is predicted that all aspects of the study will take less than 2 hours per
encounter if an interview is conducted and less than 1 hour if an interview is not
conducted.
The risk to subjects is breach in confidentiality about their disease, background
and symptom experiences. There is also a risk that asking about symptoms and how they
have affected their life in the last month could bring up negative feelings for the
participant. Referral to mental health services may be completed by the PI if deemed
necessary. It is also possible that the PI determines the participant may be currently
having an acute exacerbation of HF in which they need immediate treatment. In this case,
the participant would be referred to the clinic or emergency services, depending on
perceived severity, and the PI would follow up to ensure safety of the participant.
Adequacy of Protection Against Risks
Every member of the research team will be required to have human subjects
research training (CITI), patient privacy training (HIPAA), and any other training
deemed necessary by the IRB. Responses to questionnaires will be recorded within
REDCap® and will not be tied to any personal identifiers. No patient identifiers will be
exported to SPSS and only the PI and members of the dissertation committee will have
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access to REDCap®. Audio from interviews will be recorded on a mobile device and
uploaded to MUSC’s secure BOX server as soon as possible. An encrypted, secure, and
HIPAA compliant platform will be used for interview transcription. The audio recordings
and transcripts will be kept in a password protected, electronic folder in MUSC’s BOX
per IRB requirements. Audio recordings will be destroyed once transcriptions are
complete to protect the identity of participants.
Withdrawal of Subjects
Participants will be informed that they are allowed to withdrawal from the study
at any time or refuse any aspect of the study. If the participant wishes to be removed from
the study, the PI will not require anything in writing from the participants. Any
information collected on the participant will be destroyed and the total number of
withdrawn participants will be recorded for feasibility purposes.
Potential Benefits of the Proposed Research to Human Subjects and Others
There is no direct benefit to participants. Data from this study will be used to
potentially support feasibility of a large, mixed methods study that aims to better
understand the symptom experience and how symptoms clusters for Black women with
HFpEF. This is a notably high-risk population that could eventually benefit from research
focused on describing their symptom experience.
Importance of the Knowledge to be Gained
The proposed study has the potential impact of better understanding symptom
clusters and the symptom experience for a high-risk and understudied population.
Considering the increased burden of HF symptoms, greater risk, and worst outcomes in
females, Black Americans, and patients with HFpEF, it is especially important to study
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the symptom experience and symptom clusters in relation to gender, sex, race, and type
of HF. Also, examining the feasibility of the proposed mixed methods study would allow
others in the field to understand the nuances of recruitment and data collection for a
Black, urban population of female participants with HFpEF. Data on recruitment efforts
for an understudied population could potentially improve inclusion of the population in
future research, thus increasing generalizability of HF symptom cluster research longterm.
Study timeline:
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